<?xml version="1.0" encoding="UTF-8"?>
<svg height="785.735" width="4068.054" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="64.743" x="58.054,61.54,65.027,66.76950000000001,71.772,74.241,77.728,81.431,85.134,87.456,89.486,92.973,96.6671,100.4,102.869,107.876,109.61850000000001,113.326,117.099,120.802,124.065,127.768,129.512,133.138,134.8805,138.609,143.839,148.846,150.5885,154.311,158.084,161.348,164.974,168.238,170.268,172.59,175.854,177.736,181.0,184.194,185.9365,189.685,196.149,197.8915,201.59,205.439,207.183,209.212,212.19,215.454,218.501,221.04,224.303,225.97,229.5944,233.335,235.804,242.2861,245.977,247.644,251.131,254.618,258.105,261.591,263.2638,266.952,271.813,274.351,277.399,280.663,282.692,288.381,291.428,295.131" svgx:width="0.5,0.5,0.25,0.55,0.35,0.5,0.53,0.53,0.33,0.29,0.5,0.53,0.55,0.35,0.72,0.25,0.55,0.54,0.53,0.47,0.53,0.25,0.52,0.25,0.55,0.75,0.72,0.25,0.55,0.54,0.47,0.52,0.47,0.29,0.33,0.47,0.27,0.47,0.46,0.25,0.55,0.93,0.25,0.55,0.55,0.25,0.29,0.43,0.47,0.44,0.36,0.47,0.24,0.52,0.55,0.35,0.93,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.7,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">10. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM (2009) Treatment</text>
   <text y="72.737" x="71.773,77.506,81.132,83.161,86.139,89.626,95.299,98.347,100.6471,102.385,105.872,107.7539,109.471,115.936,119.562,121.229,123.259,125.002,128.628,131.167,134.793,138.155,140.331,145.415,148.463,150.785,152.528,154.851,156.88,160.144,163.847,165.8683,167.633,172.494,176.121,179.747,182.795,185.333,188.311,191.937,193.604,197.091,199.413,201.249,203.572,205.3145,207.032,211.7716,213.438,217.212,220.406,222.728,224.833,227.881,233.474,236.738,238.767,240.51,243.50709999999998,245.241,250.325,253.373,256.567,258.31,261.358,266.0976,267.804,271.068,274.771,278.3954,280.162,286.627,289.675,291.704,294.968" svgx:width="0.82,0.52,0.29,0.43,0.5,0.8,0.44,0.33,0.55,0.5,0.27,0.55,0.93,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31,0.73,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.25,0.55,0.68,0.55,0.54,0.46,0.33,0.29,0.44,0.8,0.47,0.29,0.25,0.43,0.55,0.73,0.44,0.46,0.25,0.44,0.68,0.55,0.47,0.53,0.52,0.55,0.93,0.44,0.29,0.47,0.31" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-</text>
   <text y="80.674" x="71.773,76.494,80.197,83.461,85.128,88.322,90.644,92.464,94.787,96.52950000000001,98.87,102.79,107.002,110.489,114.25280000000001,116.614,122.346,127.577,131.9681,134.244,137.731,139.398,142.885,144.619,146.3615,148.644,151.691,155.178,158.665,162.152,165.707" svgx:width="0.68,0.53,0.47,0.24,0.46,0.33,0.25,0.33,0.25,0.55,0.56,0.6,0.5,0.54,0.55,0.82,0.75,0.63,0.55,0.5,0.24,0.5,0.24,0.25,0.55,0.44,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Analysis. PLoS ONE 4(9): e6914.</text>
   <text y="88.667" x="58.053,61.54,65.027,66.76950000000001,71.772,76.494,80.12,83.746,87.305,90.792,92.4648,94.561,100.008,103.272,105.81,107.554,113.13,115.31,119.083,122.855,124.59750000000001,126.704,131.935,135.198,136.942,140.568,144.055,147.54000000000002,149.72,155.166,156.9085,159.017,164.386,166.925,170.412,174.038,175.705,178.753,181.26219999999998,183.449,188.171,189.9135,192.01,195.929,199.266,202.892,206.156,209.35,212.614,214.643,217.621,221.324,223.06650000000002,225.229,230.46,232.20250000000001,234.3,238.583,241.847,245.187,247.216,250.264,252.7732,254.992,259.999,261.74150000000003,263.836,266.883,268.9043,271.035,274.299,275.966,277.7085,279.822,281.489,285.038,288.525,292.012,295.499" svgx:width="0.5,0.5,0.25,0.55,0.68,0.52,0.52,0.5,0.5,0.24,0.55,0.78,0.47,0.36,0.25,0.8,0.55,0.54,0.54,0.25,0.55,0.75,0.47,0.25,0.52,0.5,0.5,0.55,0.78,0.25,0.55,0.77,0.36,0.5,0.52,0.24,0.44,0.36,0.55,0.68,0.25,0.55,0.56,0.47,0.52,0.47,0.46,0.47,0.29,0.43,0.53,0.25,0.55,0.75,0.25,0.55,0.61,0.47,0.48,0.29,0.44,0.36,0.55,0.72,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">11. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. (2010)</text>
   <text y="96.661" x="71.773,76.706,78.52,84.189,86.002,89.705,92.98089999999999,97.794,101.281,103.16290000000001,107.998,109.742,113.554,115.368,117.466,119.21,122.568,124.666,126.48,130.052,133.74609999999998,138.499,142.071,143.9529,148.704,152.048,155.752,157.888,159.702,162.31,165.428,167.526,170.065,173.648,176.842,178.694,181.302,184.647,186.3198,191.053,194.794,197.403,201.029,204.376,206.6761,211.462,215.204,218.83,221.496,223.24,227.052,230.3279,235.103,237.201,240.827,244.571,247.689,250.297,253.275,256.986,258.743,262.315,264.637,266.453,268.75309999999996,273.54,275.637,279.436,282.554,285.162,288.425,292.191,295.385" svgx:width="0.7,0.25,0.8,0.25,0.53,0.47,0.55,0.5,0.27,0.55,0.25,0.53,0.25,0.29,0.25,0.47,0.29,0.25,0.5,0.53,0.55,0.5,0.27,0.55,0.47,0.53,0.29,0.25,0.36,0.44,0.29,0.36,0.5,0.46,0.25,0.36,0.47,0.24,0.55,0.52,0.36,0.52,0.47,0.33,0.55,0.52,0.52,0.36,0.25,0.53,0.47,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.29,0.53,0.44,0.36,0.47,0.52,0.46,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Timing of initiation of antiretroviral drugs during tuberculosis therapy.</text>
   <text y="104.598" x="71.773,77.0005,79.37,83.728,87.431,90.695,92.36779999999999,94.676,97.1155,99.495,105.959,109.007,112.6314,114.971,118.458,121.945,125.432,127.17450000000001,129.54,133.027,136.514,140.001,143.487,146.974,150.461,153.948" svgx:width="0.75,0.55,0.63,0.53,0.47,0.24,0.55,0.35,0.55,0.93,0.44,0.52,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">N Engl J Med 362: 697–706.</text>
   <text y="112.592" x="58.053,61.54,65.027,66.76950000000001,71.772,78.377,81.863,84.402,86.069,89.6934,92.918,98.511,101.558,104.822,106.489,108.518,112.2121,115.423,121.156,123.694,126.958,130.222,133.925,135.668,138.646,141.91,143.939,145.683,149.17,152.86409999999998,156.069,157.736,164.34,169.933,175.74,177.4128,180.559,182.225,185.712,189.199,192.686,196.173,197.8458,201.023,206.393,210.02,211.763,215.389,218.437,220.104,221.847,225.55,228.598,230.8981,234.129,236.012,239.499,242.0082,245.184,247.214,250.917,253.9838,257.146,260.772,263.31,266.797,270.061,272.6,275.863,281.456,287.134,290.397,292.427,294.17" svgx:width="0.5,0.5,0.25,0.55,0.95,0.5,0.36,0.24,0.52,0.55,0.8,0.44,0.47,0.24,0.29,0.53,0.55,0.82,0.36,0.47,0.47,0.53,0.25,0.43,0.47,0.29,0.25,0.5,0.53,0.55,0.24,0.95,0.8,0.82,0.24,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.77,0.52,0.25,0.52,0.44,0.24,0.25,0.53,0.44,0.33,0.55,0.27,0.5,0.36,0.55,0.29,0.53,0.44,0.55,0.52,0.36,0.5,0.47,0.36,0.47,0.8,0.8,0.47,0.29,0.25,0.43" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">12. World Health Organization (WHO) (2008) Guidelines for the programmatic</text>
   <text y="120.529" x="71.773,77.366,80.63,84.333,87.597,90.934,93.981,99.574,102.622,106.325,108.3463,110.718,114.204,116.0859,118.428,122.054,124.593,128.219,131.483,133.659,136.197,139.245,141.567,143.31,145.633,147.662,150.926,154.629,156.6503,159.073,161.103,164.729,168.355,171.403,173.941,176.919,180.546,182.212,185.699,188.021,189.765,192.06509999999997,194.504,198.862,204.455,207.503,210.041,213.305,216.352,220.056,223.033,226.23919999999998,228.63,234.0,237.626,241.252,244.516,246.546,249.6128,251.986,255.473,258.96,262.447,265.933,267.6755,270.013,275.384,278.431,282.134,285.182,288.376,291.555" svgx:width="0.8,0.47,0.53,0.47,0.47,0.44,0.8,0.44,0.53,0.29,0.55,0.5,0.27,0.55,0.52,0.36,0.52,0.47,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.63,0.8,0.44,0.36,0.47,0.44,0.53,0.43,0.46,0.55,0.77,0.52,0.52,0.47,0.29,0.44,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.77,0.44,0.53,0.44,0.46,0.47,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">management of drug-resistant tuberculosis Emergency Update 2008. Geneva.</text>
   <text y="128.522" x="58.053,61.54,65.027,66.76950000000001,71.772,75.545,78.593,82.219,85.922,89.19789999999999,91.443,96.89,99.359,101.1015,103.291,109.024,114.686,117.95,119.979,123.243,126.437,129.922,132.147,137.447,141.729,143.47150000000002,145.695,151.142,154.189,156.512,160.215,163.479,166.673,168.416,171.545,174.6118,176.761,180.534,182.2765,184.528,188.378,192.004,194.543,196.286,199.9801,202.215,204.684,207.153,208.8955,211.115,214.965,218.228,220.767,226.36,229.407,231.9162,234.187,238.107,242.465,244.2075,246.432,249.479,251.5003,253.688,256.952,258.619,260.36150000000004,262.588,264.255,267.742,271.229,274.716,278.202,279.8748,282.089,286.448,289.711,292.25,293.917" svgx:width="0.5,0.5,0.25,0.55,0.54,0.44,0.52,0.53,0.47,0.55,0.78,0.35,0.25,0.55,0.82,0.8,0.47,0.29,0.47,0.46,0.5,0.55,0.76,0.61,0.25,0.55,0.78,0.44,0.33,0.53,0.47,0.46,0.25,0.44,0.44,0.55,0.54,0.25,0.55,0.55,0.52,0.36,0.25,0.53,0.55,0.35,0.35,0.25,0.55,0.55,0.47,0.36,0.8,0.44,0.36,0.55,0.56,0.63,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.63,0.47,0.36,0.24,0.46" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">13. Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, et al. (2009) Early</text>
   <text y="136.516" x="71.773,75.26,78.886,80.916,83.961,87.448,93.041,96.089,98.3891,100.571,104.058,105.93990000000001,108.111,114.576,119.876,124.96,127.136,131.997,136.2487,138.44,140.469,143.008,146.055,149.319,151.348,157.034,160.082,163.785,165.8063,167.975,169.719,173.4131,175.572,178.8479,180.958,184.661,186.404,189.668,193.3621,195.584,201.177,203.646,208.729,210.905,214.532,217.07,220.118,223.312,226.575,228.242,231.29,235.095,238.073,241.1398,243.259,245.581,248.629,250.658,252.687,254.431,258.134,261.4099,263.61,265.354,269.0481,271.207,274.98,278.467,282.094,284.123,287.826,290.874,293.412" svgx:width="0.5,0.52,0.29,0.43,0.5,0.8,0.44,0.33,0.55,0.5,0.27,0.55,0.93,0.76,0.73,0.31,0.7,0.61,0.55,0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.25,0.53,0.55,0.47,0.55,0.53,0.25,0.47,0.53,0.55,0.8,0.35,0.73,0.31,0.52,0.36,0.44,0.46,0.47,0.24,0.44,0.53,0.43,0.44,0.55,0.33,0.44,0.29,0.29,0.25,0.53,0.47,0.55,0.25,0.53,0.55,0.54,0.5,0.52,0.29,0.53,0.44,0.36,0.53" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern</text>
   <text y="144.452" x="71.773,76.495,78.379,80.918,82.662,85.64,88.905,90.64750000000001,93.035,96.955,101.168,104.656,108.41980000000001,110.781,116.514,121.745,126.1361,128.469,131.957,133.624,137.112,138.779,140.5215,142.871,145.919,149.407,152.894,156.382,159.87" svgx:width="0.68,0.27,0.36,0.25,0.43,0.47,0.25,0.55,0.56,0.6,0.5,0.54,0.55,0.82,0.75,0.63,0.55,0.5,0.24,0.5,0.24,0.25,0.55,0.44,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Africa. PLoS ONE 4(9): e7186.</text>
   <text y="152.446" x="58.053,61.54,65.027,66.76950000000001,71.772,78.377,81.863,84.402,86.069,89.6934,93.598,99.191,102.238,105.502,107.169,109.198,112.8921,116.84,122.572,125.111,128.375,131.638,135.341,137.085,140.063,143.427,145.456,147.2,150.686,154.3801,158.28,159.946,166.55,172.143,177.876,179.5488,183.449,185.116,188.603,192.09,195.577,199.064,200.7368,204.651,209.372,213.075,215.105,216.848,219.387,222.434,224.464,227.002,230.489,233.683,235.426,237.965,241.328,243.0008,246.828,248.857,252.56,255.608,258.222,261.486,265.113,268.3192,272.168,274.051,277.538,280.04720000000003,284.016,289.609,292.078" svgx:width="0.5,0.5,0.25,0.55,0.95,0.5,0.36,0.24,0.52,0.55,0.8,0.44,0.47,0.24,0.29,0.53,0.55,0.82,0.36,0.47,0.47,0.53,0.25,0.43,0.47,0.29,0.25,0.5,0.53,0.55,0.24,0.95,0.8,0.82,0.24,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.68,0.53,0.29,0.25,0.36,0.44,0.29,0.36,0.5,0.46,0.25,0.36,0.47,0.24,0.55,0.29,0.53,0.44,0.36,0.47,0.52,0.46,0.55,0.27,0.5,0.36,0.55,0.8,0.35,0.73" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">14. World Health Organization (WHO) (2010) Antiretroviral therapy for HIV</text>
   <text y="160.383" x="71.773,73.517,77.22,79.103,82.15,85.128,87.157,88.901,92.464,96.1581,100.175,101.918,105.61210000000001,109.642,112.906,116.532,120.159,121.825,123.855,126.1551,130.277,133.541,137.244,140.8684,144.903,148.167,151.793,155.28,156.947,159.994,162.317,165.294,168.428,172.132,174.161,176.483,178.2255,182.261,187.345,190.392,193.37,196.857,202.45,208.111,211.158,214.861,218.488,221.752,223.781,225.524,229.011,232.714,235.01409999999998,239.119,241.002,244.489,246.9982,251.081,254.3569,258.337,261.964,265.59,269.217,270.883,272.627,275.6241,279.709,283.412,286.46,289.724,291.391,293.42" svgx:width="0.25,0.53,0.27,0.44,0.43,0.29,0.25,0.5,0.53,0.55,0.25,0.53,0.55,0.47,0.52,0.52,0.24,0.29,0.33,0.55,0.47,0.53,0.52,0.55,0.47,0.52,0.5,0.24,0.44,0.33,0.43,0.44,0.53,0.29,0.33,0.25,0.55,0.73,0.44,0.43,0.5,0.8,0.8,0.44,0.53,0.52,0.47,0.29,0.25,0.5,0.53,0.33,0.55,0.27,0.5,0.36,0.55,0.47,0.55,0.52,0.52,0.52,0.24,0.25,0.43,0.55,0.53,0.44,0.47,0.24,0.29,0.53" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">infection in adults and adolescents. Recommendations for a public health</text>
   <text y="168.376" x="71.773,75.037,78.663,82.29,84.828,88.315,91.671,94.649,98.352,100.09450000000001,102.385,105.872,109.359,112.846,116.331,118.712,121.25,124.298,127.492,129.235,131.557,133.301,136.788,140.491,142.23350000000002,144.618,149.988,153.036,156.739,159.787,162.981,166.244" svgx:width="0.47,0.52,0.52,0.36,0.5,0.47,0.43,0.53,0.25,0.55,0.5,0.5,0.5,0.5,0.55,0.36,0.44,0.46,0.25,0.33,0.25,0.5,0.53,0.25,0.55,0.77,0.44,0.53,0.44,0.46,0.47,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">approach. 2010 revision. Geneva.</text>
   <text y="176.313" x="58.053,61.54,65.027,66.76950000000001,71.772,75.985,79.248,81.571,84.618,87.157,89.479,92.966,96.6601,99.834,105.28,109.13,110.8725,114.063,118.924,122.627,126.114,128.652,132.278,135.3448,138.496,142.708,147.066,148.8085,151.931,156.143,159.19,160.934,166.527,169.79,173.494,176.5608,179.708,184.793,186.5355,189.686,196.291,199.339,202.533,205.58,208.0892,211.285,216.732,218.4745,221.603,228.068,229.811,231.841,235.544,237.287,240.265,243.47119999999998,246.603,251.61,256.91,258.65250000000003,261.795,264.843,266.8643,270.015,273.279,274.946,276.68850000000003,279.822,281.489,284.976,288.463,292.011,295.497" svgx:width="0.5,0.5,0.25,0.55,0.6,0.47,0.33,0.44,0.36,0.33,0.5,0.53,0.55,0.78,0.55,0.25,0.55,0.7,0.53,0.5,0.36,0.52,0.44,0.55,0.6,0.63,0.25,0.55,0.6,0.44,0.25,0.8,0.47,0.53,0.44,0.55,0.73,0.25,0.55,0.95,0.44,0.46,0.44,0.36,0.55,0.78,0.25,0.55,0.93,0.25,0.29,0.53,0.25,0.43,0.46,0.55,0.72,0.76,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">15. Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, et al. (2005)</text>
   <text y="184.306" x="71.773,75.546,79.172,82.22,85.484,88.678,90.421,94.124,97.39989999999999,101.364,103.394,107.097,110.1638,114.006,116.329,119.592,125.185,128.2518,132.147,133.814,137.078,140.781,144.045,147.671,151.025,154.288,157.336,159.07850000000002,162.986,165.016,167.554,170.602,173.865,175.895,181.488,184.535,188.238,190.2593,194.221,197.708,201.334,203.364,206.342,209.828,215.421,218.4878,222.395,226.022,229.07,230.953,232.696,236.399,238.143,240.172,241.916,245.402,249.106,251.40609999999998,255.388,257.271,260.758,263.2672,267.18,272.773,276.399,278.066,280.095,281.839,285.547,288.085,291.711,294.975" svgx:width="0.54,0.52,0.44,0.47,0.46,0.25,0.53,0.47,0.55,0.29,0.53,0.44,0.55,0.33,0.47,0.8,0.44,0.55,0.24,0.47,0.53,0.47,0.52,0.47,0.47,0.44,0.25,0.55,0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.5,0.52,0.29,0.43,0.5,0.8,0.44,0.55,0.52,0.44,0.27,0.25,0.53,0.25,0.29,0.25,0.5,0.53,0.33,0.55,0.27,0.5,0.36,0.55,0.8,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Speaking the same language: treatment outcome definitions for multidrug-</text>
   <text y="192.3" x="71.773,74.312,77.359,79.681,81.425,83.747,85.776,89.12,92.823,94.84429999999999,97.17,99.199,102.825,106.452,109.499,112.038,115.015,118.642,120.309,123.795,126.118,127.861,130.183,131.9255,134.357,136.825,140.528,142.5493,144.901,147.34050000000002,149.663,154.524,158.151,161.852,164.899,167.438,170.43509999999998,172.736,176.948,180.575,184.278,187.5539,189.913,195.213,196.957,199.279,201.0215,203.348,205.015,208.502,210.169,211.91150000000002,214.29,217.776,221.263,224.75,228.237,231.724" svgx:width="0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.25,0.55,0.35,0.53,0.29,0.55,0.35,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.55,0.6,0.52,0.53,0.47,0.55,0.76,0.25,0.33,0.25,0.55,0.24,0.5,0.24,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">resistant tuberculosis. Int J Tuberc Lung Dis. (6): 640–5.</text>
   <text y="200.237" x="58.053,61.54,65.027,66.76950000000001,71.772,75.545,77.289,80.992,84.255,85.922,89.19789999999999,91.443,96.527,98.26950000000001,100.457,104.23,107.494,110.032,111.851,115.5451,117.748,122.832,124.5745,126.762,132.209,135.912,139.176,140.842,142.586,146.21040000000002,148.474,153.843,159.29,161.0325,163.269,169.734,172.998,175.027,178.73,182.357,184.895,186.638,189.9139,192.181,197.627,199.36950000000002,201.535,205.307,207.051,210.754,214.018,215.763,219.0389,221.205,226.436,228.1785,230.389,233.437,235.4583,237.703,240.966,242.633,244.37550000000002,246.603,248.269,251.756,255.243,258.73,262.217,263.8898,266.103,269.876,272.924,276.118,279.165,282.868,285.044,288.238,291.286,294.55" svgx:width="0.5,0.5,0.25,0.55,0.54,0.25,0.53,0.47,0.24,0.47,0.55,0.73,0.25,0.55,0.54,0.47,0.36,0.25,0.53,0.55,0.73,0.25,0.55,0.78,0.53,0.47,0.24,0.25,0.52,0.55,0.77,0.78,0.25,0.55,0.93,0.47,0.29,0.53,0.52,0.36,0.25,0.47,0.55,0.78,0.25,0.55,0.54,0.25,0.53,0.47,0.24,0.47,0.55,0.75,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.54,0.44,0.46,0.44,0.53,0.31,0.46,0.44,0.47,0.36" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">16. Singla R, Sarin R, Khalid UK, Mathuria K, Singla N, et al. (2009) Seven-year</text>
   <text y="208.231" x="71.773,77.073,82.806,87.666,91.439,93.615,97.623,99.29,102.916,105.2161,106.92,110.547,112.29,113.957,117.444,119.4653,121.149,124.197,127.537,131.163,134.211,136.749,138.493,141.54,145.243,148.302,151.3688,153.007,154.751,158.4451,160.151,162.619,166.322,169.949,171.692,174.956,176.6985,178.405,180.943,183.991,186.313,189.939,191.606,193.635,195.958,197.7005,199.436,202.414,205.901,209.604,211.926,213.956,216.494,219.758,221.501,225.204,227.234,229.5341,231.295,234.558,238.261,241.8854,243.54,245.283,247.606,249.928,253.63,256.678,259.0,260.7425,262.417,264.886,268.589,270.6103,272.281,274.7205,276.419,281.28,284.906,288.533,291.58,294.119" svgx:width="0.76,0.82,0.7,0.54,0.31,0.56,0.24,0.52,0.33,0.55,0.52,0.25,0.24,0.5,0.29,0.55,0.44,0.48,0.52,0.44,0.36,0.25,0.44,0.53,0.43,0.44,0.55,0.25,0.53,0.55,0.35,0.53,0.52,0.25,0.47,0.25,0.55,0.36,0.44,0.33,0.52,0.24,0.29,0.33,0.25,0.55,0.43,0.5,0.53,0.33,0.29,0.36,0.47,0.25,0.53,0.29,0.33,0.55,0.47,0.53,0.52,0.55,0.25,0.33,0.33,0.52,0.44,0.33,0.25,0.55,0.35,0.53,0.29,0.55,0.35,0.55,0.7,0.52,0.52,0.44,0.36,0.43" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">DOTS-Plus pilot experience in India: results, constraints and issues. Int J Tuberc</text>
   <text y="216.167" x="71.773,75.986,79.613,83.317,86.59289999999999,88.952,94.252,95.997,98.32,100.0625,102.389,106.016,109.6404,112.027,115.514,119.002,122.489,125.977,129.465,132.952,136.44" svgx:width="0.6,0.52,0.53,0.47,0.55,0.76,0.25,0.33,0.25,0.55,0.52,0.52,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Lung Dis. pp 976–981.</text>
   <text y="224.161" x="58.053,61.54,65.027,66.76950000000001,71.772,74.241,77.728,80.05,83.098,86.795,90.48910000000001,93.088,97.008,98.7505,101.365,106.666,109.713,112.036,115.299,117.04150000000001,119.676,124.76,129.042,130.7845,133.395,139.86,143.347,147.05,150.313,154.00709999999998,156.637,161.868,165.64,167.3825,170.016,173.865,176.404,179.451,183.078,185.616,187.36,190.337,193.54319999999998,196.149,198.618,202.391,204.1335,206.75,211.835,215.099,220.692,223.955,226.933,230.636,233.9,237.703,241.329,243.868,247.131,250.8251,253.462,258.546,260.2885,262.873,265.92,267.9413,270.583,273.847,275.513,277.2555,279.823,281.49,284.977,288.464,292.011,295.498" svgx:width="0.5,0.5,0.25,0.55,0.35,0.5,0.33,0.44,0.52,0.53,0.55,0.56,0.25,0.55,0.76,0.44,0.33,0.47,0.25,0.55,0.73,0.61,0.25,0.55,0.93,0.5,0.53,0.47,0.53,0.55,0.75,0.54,0.25,0.55,0.55,0.36,0.44,0.52,0.36,0.25,0.43,0.46,0.55,0.35,0.54,0.25,0.55,0.73,0.47,0.8,0.47,0.43,0.53,0.47,0.53,0.52,0.36,0.47,0.53,0.55,0.73,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">17. Joseph P, Desai VB, Mohan NS, Fredrick JS, Ramachandran R, et al. (2011)</text>
   <text y="232.155" x="71.773,77.506,81.132,83.161,86.139,89.626,95.299,98.36580000000001,101.592,105.079,106.9609,110.209,112.531,114.561,117.825,121.604,125.23,128.494,131.032,134.659,136.402,139.38,142.427,146.0514,149.381,151.41,153.949,156.996,160.26,162.289,167.882,170.93,174.633,176.6543,179.992,181.875,185.362,187.8712,191.16,194.787,198.05,200.08,201.823,204.871,208.574,210.603,212.9031,216.216,220.938,222.681,224.777,228.47109999999998,231.693,238.158,243.458,248.542,250.797,255.658,259.9097,263.213,265.096,267.634,271.121,276.697,279.993,284.854,288.118,293.711,295.454" svgx:width="0.82,0.52,0.29,0.43,0.5,0.8,0.44,0.55,0.5,0.27,0.55,0.33,0.29,0.47,0.53,0.52,0.47,0.36,0.52,0.25,0.43,0.44,0.52,0.55,0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.27,0.5,0.36,0.55,0.52,0.47,0.29,0.25,0.44,0.53,0.29,0.33,0.55,0.68,0.25,0.29,0.53,0.55,0.93,0.76,0.73,0.31,0.7,0.61,0.55,0.27,0.36,0.5,0.8,0.55,0.7,0.47,0.8,0.25,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Outcome of standardized treatment for patients with MDR-TB from Tamil</text>
   <text y="240.092" x="71.773,77.003,80.267,83.961,87.588,89.3305,91.615,94.084,97.851,101.478,103.221,106.485,108.2275,110.55,113.019,116.722,120.348,122.092,125.356,129.0501,131.412,133.85150000000002,136.23,142.696,145.743,149.3674,151.707,156.791,159.839,162.13909999999998,164.519,168.007,171.493,174.98,176.647,180.134,181.801,183.5435,185.891,189.378,192.865,196.352,199.838,203.325,206.812,210.299" svgx:width="0.75,0.47,0.52,0.52,0.25,0.55,0.35,0.53,0.52,0.25,0.47,0.25,0.55,0.35,0.53,0.52,0.25,0.47,0.53,0.55,0.35,0.55,0.93,0.44,0.52,0.55,0.73,0.44,0.33,0.55,0.5,0.5,0.5,0.24,0.5,0.24,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Nadu, India. Indian J Med Res 133(5): 529–534.</text>
   <text y="248.085" x="58.053,61.54,65.027,66.76950000000001,71.772,78.237,79.981,82.01,85.713,87.456,90.434,93.6402,95.468,100.475,102.2175,103.971,108.253,111.517,114.711,118.198,121.901,125.17689999999999,126.987,129.455,131.19750000000002,132.996,136.916,140.18,141.846,145.11,148.088,149.831,153.318,155.6181,157.429,161.788,163.53050000000002,165.309,169.082,172.849,174.593,178.28709999999998,180.049,183.822,185.5645,187.362,191.211,194.838,197.376,199.12,202.8141,204.595,207.064,208.8065,210.605,213.652,215.67329999999998,217.464,220.728,222.395,224.13750000000002,225.911,227.577,231.064,234.551,238.038,241.525,243.1978,245.015,250.022,253.509,259.102,264.695,268.321,272.024,273.768,275.797,278.991,281.167,284.793,288.154,290.476,293.524" svgx:width="0.5,0.5,0.25,0.55,0.93,0.25,0.29,0.53,0.25,0.43,0.46,0.55,0.72,0.25,0.55,0.61,0.47,0.46,0.5,0.53,0.47,0.55,0.35,0.25,0.55,0.56,0.47,0.24,0.47,0.43,0.25,0.5,0.33,0.55,0.63,0.25,0.55,0.54,0.53,0.25,0.53,0.55,0.54,0.25,0.55,0.55,0.52,0.36,0.25,0.53,0.55,0.35,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.72,0.5,0.8,0.8,0.52,0.53,0.25,0.29,0.46,0.31,0.52,0.47,0.33,0.44,0.52" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">18. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, et al. (2003) Community-based</text>
   <text y="256.022" x="71.773,73.802,77.506,80.553,83.092,86.355,89.982,93.1882,95.696,97.579,101.066,103.5752,106.07,111.663,115.29,116.956,118.986,120.729,124.355,126.894,130.52,133.784,135.96,138.498,141.546,143.868,145.612,147.934,149.963,153.348,157.051,159.07229999999998,161.511,163.541,167.167,170.793,173.841,176.379,179.357,182.984,184.65,188.137,190.459,192.203,194.5031,197.055,198.798,202.4921,204.935,209.147,210.891,216.484,219.747,221.48950000000002,223.925,227.845,230.893,233.507,237.133,238.87550000000002,241.33,246.5575,248.984,253.342,257.045,260.309,261.9818,264.403,266.84250000000003,269.335,275.8,278.848,282.4724,284.925,288.412,291.899,295.386" svgx:width="0.29,0.53,0.44,0.36,0.47,0.52,0.46,0.55,0.27,0.5,0.36,0.55,0.8,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.25,0.53,0.55,0.6,0.25,0.8,0.47,0.25,0.55,0.56,0.44,0.36,0.52,0.25,0.55,0.75,0.55,0.63,0.53,0.47,0.24,0.55,0.35,0.55,0.93,0.44,0.52,0.55,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 348:</text>
   <text y="264.015" x="71.773,75.26,78.747,82.234,85.721,89.208,92.694,96.181" svgx:width="0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">119–128.</text>
   <text y="271.952" x="58.053,61.54,65.027,66.76950000000001,71.772,75.985,79.032,80.776,86.369,89.632,93.335,96.4018,98.926,104.011,105.7535,108.281,113.365,115.109,118.156,121.35,123.673,125.702,127.446,131.149,134.4249,136.966,142.051,143.7935,146.321,151.914,155.401,157.067,159.097,162.0941,164.575,169.436,175.028,176.7705,179.314,183.742,187.006,189.544,193.031,196.225,198.548,201.742,205.0179,207.545,211.903,213.6455,216.161,219.934,223.128,225.667,227.41,231.036,234.014,237.501,241.204,244.691,247.963,251.2389,253.746,258.831,260.5735,263.044,266.092,268.1133,270.641,273.904,275.571,277.31350000000003,279.824,281.491,284.978,288.465,292.013,295.499" svgx:width="0.5,0.5,0.25,0.55,0.6,0.44,0.25,0.8,0.47,0.53,0.44,0.55,0.73,0.25,0.55,0.73,0.25,0.44,0.46,0.33,0.29,0.25,0.53,0.47,0.55,0.73,0.25,0.55,0.8,0.5,0.24,0.29,0.43,0.55,0.7,0.8,0.25,0.55,0.63,0.47,0.36,0.5,0.46,0.33,0.46,0.47,0.55,0.63,0.25,0.55,0.54,0.46,0.36,0.25,0.52,0.43,0.5,0.53,0.5,0.46,0.47,0.55,0.73,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">19. Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, et al. (2005)</text>
   <text y="279.946" x="71.773,76.78,78.447,80.19,83.961,85.705,88.682,91.946,93.6188,95.923,99.41,103.036,105.065,108.043,111.53,117.123,120.1898,122.566,126.053,127.9349,130.219,131.963,135.666,139.292,141.103,144.297,146.041,149.667,153.293,156.557,158.224,159.967,162.289,165.337,168.9614,171.318,173.347,175.886,178.933,182.197,184.226,189.912,192.96,196.663,198.6843,201.023,204.511,206.3929,208.734,214.327,217.954,219.62,221.65,223.393,227.02,229.558,233.184,236.448,238.624,241.162,244.21,246.532,248.276,250.598,252.627,256.012,259.715,261.73629999999997,264.062,266.091,269.717,273.344,276.391,278.93,281.908,285.534,287.201,290.688,293.01,294.753" svgx:width="0.72,0.24,0.25,0.53,0.25,0.43,0.47,0.24,0.55,0.5,0.52,0.29,0.43,0.5,0.8,0.44,0.55,0.5,0.27,0.55,0.25,0.53,0.52,0.25,0.46,0.25,0.52,0.52,0.47,0.24,0.25,0.33,0.44,0.52,0.55,0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.5,0.27,0.55,0.8,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Clinical outcome of individualised treatment of multidrug-resistant tuberculosis</text>
   <text y="287.939" x="71.773,73.517,77.2111,79.54,83.752,87.08,89.109,92.303,94.047,97.31,99.05250000000001,101.366,104.64189999999999,106.978,109.517,112.564,114.594,117.132,120.619,122.941,126.649,129.697,132.675,134.704,136.447,139.641,142.7078,145.016,147.994,151.481,155.184,158.671,161.209,163.2303,165.594,167.916,169.945,173.572,177.198,180.392,182.1345,184.528,188.74,192.003,195.707,198.684,201.732,203.7533,206.126,209.613,213.1,216.587,218.3295,220.695,224.182,227.669,231.156,234.643,238.13,241.616,245.103" svgx:width="0.25,0.53,0.55,0.6,0.47,0.29,0.46,0.25,0.47,0.25,0.55,0.47,0.55,0.36,0.44,0.29,0.36,0.5,0.33,0.52,0.44,0.43,0.29,0.25,0.46,0.44,0.55,0.43,0.5,0.53,0.5,0.36,0.29,0.55,0.33,0.29,0.52,0.52,0.46,0.25,0.55,0.6,0.47,0.53,0.43,0.44,0.29,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">in Latvia: a retrospective cohort study. Lancet 365: 318–326.</text>
   <text y="295.876" x="58.053,61.54,65.027,66.76950000000001,71.772,75.545,79.248,80.992,84.68610000000001,87.872,91.645,95.418,97.16050000000001,100.287,104.206,107.47,109.792,112.84,115.817,119.521,123.224,124.967,128.161,131.648,134.8542,138.041,142.762,148.062,149.80450000000002,152.894,158.264,161.311,162.978,168.653,171.917,175.62,179.107,182.301,185.5769,188.721,191.19,195.911,197.6535,200.739,204.659,207.706,210.245,213.292,218.885,220.629,222.734,224.478,228.1721,231.295,236.664,242.034,243.7765,246.941,250.714,252.743,255.282,258.329,259.996,261.739,264.03909999999996,267.235,271.957,277.403,279.1455,282.258,285.306,287.3273,290.478,293.742,295.409" svgx:width="0.5,0.5,0.25,0.55,0.54,0.53,0.25,0.53,0.55,0.54,0.54,0.25,0.55,0.56,0.47,0.33,0.44,0.43,0.53,0.53,0.25,0.46,0.5,0.46,0.55,0.68,0.76,0.25,0.55,0.77,0.44,0.24,0.8,0.47,0.53,0.5,0.46,0.47,0.55,0.35,0.68,0.25,0.55,0.56,0.44,0.36,0.44,0.8,0.25,0.29,0.25,0.53,0.55,0.77,0.77,0.25,0.55,0.54,0.29,0.36,0.44,0.24,0.25,0.33,0.55,0.68,0.78,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">20. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, et al.</text>
   <text y="303.869" x="71.773,73.44,76.927,80.414,83.961,87.449,89.1218,92.863,97.724,100.262,103.31,106.574,108.603,114.292,117.339,121.042,123.0633,126.877,130.363,133.99,136.019,138.997,142.484,148.077,151.124,153.42409999999998,157.261,159.005,162.6991,166.502,169.766,173.46009999999998,177.273,179.017,182.72,184.749,187.797,191.061,193.599,196.863,198.892,201.94,205.5644,209.416,212.393,214.137,217.331,219.074,220.741,222.485,225.748,229.44209999999998,233.282,236.546,240.249,243.8734,247.682,251.309,253.847,255.591,257.913,261.4,265.09409999999997,268.941,275.405,280.705,285.789,287.965,292.826" svgx:width="0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.7,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.5,0.52,0.29,0.43,0.5,0.8,0.44,0.33,0.55,0.25,0.53,0.55,0.47,0.53,0.55,0.25,0.53,0.29,0.44,0.47,0.36,0.47,0.29,0.44,0.52,0.55,0.43,0.25,0.46,0.25,0.24,0.25,0.47,0.53,0.55,0.47,0.53,0.52,0.55,0.52,0.36,0.25,0.33,0.5,0.53,0.55,0.93,0.76,0.73,0.31,0.7,0.61" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">(2006) Treatment outcomes in an integrated civilian and prison MDR-TB</text>
   <text y="311.806" x="71.773,73.802,76.341,79.388,82.652,84.682,90.275,93.322,97.112,99.13329999999999,101.478,105.105,107.643,111.13,114.394,116.933,120.196,125.77199999999999,128.179,129.923,133.6171,135.946,141.03,144.656,146.979,149.301,151.044,154.308,156.0505,158.395,160.863,164.566,166.5873,168.939,171.3785,173.758,178.619,182.245,185.871,188.919,191.457,194.45409999999998,196.83,201.042,204.669,208.372,211.64790000000002,214.007,219.307,221.051,223.35109999999997,225.686,229.172,232.659,234.4015,236.74,240.227,243.713,247.2,250.687,254.174,257.661,261.148" svgx:width="0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.52,0.36,0.5,0.47,0.36,0.47,0.8,0.55,0.25,0.53,0.55,0.73,0.52,0.33,0.33,0.25,0.47,0.25,0.55,0.35,0.53,0.29,0.55,0.35,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.55,0.6,0.52,0.53,0.47,0.55,0.76,0.25,0.33,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">treatment program in Russia. Int J Tuberc Lung Dis 10: 402–408.</text>
   <text y="319.8" x="58.053,61.54,65.027,66.76950000000001,71.772,76.633,80.259,83.96,87.224,89.546,91.28850000000001,94.958,99.819,104.178,105.9205,109.584,114.954,118.58,122.207,124.236,127.5119,131.183,136.267,138.0095,141.671,147.403,151.03,154.077,155.744,159.008,162.634,164.377,167.86200000000002,171.602,178.067,180.536,182.2785,185.945,191.678,194.216,195.96,197.626,199.293,202.557,205.616,208.89190000000002,212.533,217.617,221.899,223.6415,227.329,233.793,235.537,238.075,241.3509,245.015,250.246,255.33,257.0725,260.775,263.822,265.8433,269.505,272.769,274.436,276.1785,279.823,281.49,284.977,288.464,292.011,295.498" svgx:width="0.5,0.5,0.25,0.55,0.7,0.52,0.52,0.47,0.33,0.25,0.55,0.7,0.63,0.25,0.55,0.77,0.52,0.52,0.29,0.47,0.55,0.73,0.25,0.55,0.82,0.52,0.44,0.24,0.47,0.52,0.25,0.5,0.55,0.93,0.35,0.25,0.55,0.82,0.36,0.25,0.24,0.24,0.47,0.43,0.47,0.55,0.73,0.61,0.25,0.55,0.93,0.25,0.36,0.47,0.55,0.75,0.73,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">21. Tupasi TE, Gupta R, Quelapio MI, Orillaza RB, Mira NR, et al. (2006)</text>
   <text y="327.793" x="71.773,75.623,78.67,81.934,84.256,86.0,89.626,91.444,93.111,94.854,96.884,100.0902,103.066,106.33,110.033,113.6574,116.672,119.65,123.136,125.459,127.488,129.664,132.712,134.594,136.477,139.525,142.503,144.532,146.376,149.57,152.617,156.321,159.368,161.69,163.99009999999998,167.011,170.498,172.3799,175.401,177.43,179.969,183.016,186.28,188.309,190.053,193.756,197.0319,200.06,205.654,209.28,210.947,212.976,214.72,218.346,220.885,224.511,227.775,229.951,232.489,235.537,237.859,239.602,241.925,243.954,247.338,251.042,253.0633,256.069,258.098,261.725,265.351,268.399,270.937,273.915,277.541,279.208,282.695,285.017,286.761,289.083,290.82550000000003,293.88" svgx:width="0.55,0.44,0.47,0.33,0.25,0.52,0.25,0.24,0.25,0.29,0.46,0.55,0.47,0.53,0.52,0.55,0.43,0.5,0.33,0.29,0.31,0.44,0.27,0.27,0.44,0.43,0.29,0.25,0.46,0.44,0.53,0.44,0.33,0.33,0.55,0.5,0.27,0.55,0.29,0.36,0.44,0.47,0.29,0.25,0.53,0.47,0.55,0.8,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.25,0.55,0.47" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a</text>
   <text y="335.73" x="71.773,74.751,78.238,81.941,85.428,87.966,89.98729999999999,92.351,94.673,96.702,100.329,103.955,107.1612,109.527,111.271,114.9651,117.294,119.323,123.026,126.0928,128.462,132.381,136.084,137.827,139.494,141.238,144.864,148.49,150.234,153.937,156.985,159.307,161.0495,163.438,167.357,171.57,175.056,178.81980000000001,181.182,187.647,190.694,194.3184,196.658,200.145,201.88750000000002,204.255,207.303,210.789,214.276,217.763" svgx:width="0.43,0.5,0.53,0.5,0.36,0.29,0.55,0.33,0.29,0.52,0.52,0.46,0.55,0.25,0.53,0.55,0.29,0.53,0.44,0.55,0.56,0.53,0.25,0.24,0.25,0.52,0.52,0.25,0.53,0.44,0.33,0.25,0.55,0.56,0.6,0.5,0.54,0.55,0.93,0.44,0.52,0.55,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">cohort study in the Philippines. PLoS Med 3: e352.</text>
   <text y="343.724" x="58.053,61.54,65.027,66.76950000000001,71.772,78.237,81.863,84.402,86.94,90.204,93.41019999999999,97.509,99.978,101.7205,105.729,109.502,112.989,116.692,120.468,123.516,127.219,130.845,133.893,136.431,139.70690000000002,143.768,147.687,149.42950000000002,153.462,157.235,160.938,163.986,167.249,169.788,172.835,175.3442,179.482,183.255,188.262,190.0045,194.051,199.421,202.908,206.534,208.417,210.955,214.003,217.197,219.373,223.222,226.59,230.217,232.539,234.862,237.909,239.939,241.9603,246.035,249.9382,253.972,255.639,259.126,262.612,266.16,269.647,271.3198,275.344,280.937,284.563,290.156,293.42" svgx:width="0.5,0.5,0.25,0.55,0.93,0.52,0.36,0.36,0.47,0.46,0.55,0.35,0.25,0.55,0.54,0.5,0.53,0.53,0.44,0.53,0.52,0.44,0.36,0.47,0.55,0.56,0.25,0.55,0.54,0.53,0.44,0.47,0.36,0.44,0.36,0.55,0.54,0.72,0.25,0.55,0.77,0.5,0.52,0.27,0.36,0.44,0.46,0.31,0.55,0.47,0.52,0.33,0.33,0.44,0.29,0.29,0.55,0.56,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.8,0.52,0.8,0.47,0.53" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">22. Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P (1999) Human</text>
   <text y="351.661" x="71.773,73.517,79.109,84.702,88.329,92.032,95.519,99.145,102.271,104.154,105.897,108.875,110.619,113.666,117.369,120.347,123.55319999999999,126.307,129.501,131.244,133.846,137.473,139.7731,142.519,145.783,149.486,153.1104,155.898,157.927,161.63,164.6968,167.463,170.95,174.576,176.605,179.583,183.07,188.663,191.7298,194.503,197.99,199.8719,202.666,204.696,207.234,210.282,213.546,215.575,221.168,224.215,227.919,229.9403,232.768,234.651,238.138,240.6472,243.426,247.129,250.177,254.9166,257.655,260.919,264.622,268.2464,271.034,273.572,276.62,279.598,283.224,285.763,288.381,291.428,295.131" svgx:width="0.25,0.8,0.8,0.52,0.53,0.5,0.52,0.44,0.27,0.25,0.43,0.25,0.44,0.53,0.43,0.46,0.55,0.46,0.25,0.36,0.52,0.33,0.55,0.47,0.53,0.52,0.55,0.29,0.53,0.44,0.55,0.5,0.52,0.29,0.43,0.5,0.8,0.44,0.55,0.5,0.27,0.55,0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.27,0.5,0.36,0.55,0.53,0.44,0.68,0.55,0.47,0.53,0.52,0.55,0.36,0.44,0.43,0.52,0.36,0.36,0.44,0.53,0.29" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">immunodeficiency virus and the outcome of treatment for new and recurrent</text>
   <text y="359.654" x="71.773,75.399,79.026,80.693,86.286,89.772,93.476,96.829,99.368,102.57419999999999,105.276,107.305,110.932,114.558,117.606,120.144,123.122,126.748,128.415,131.902,134.224,135.968,138.26809999999998,141.046,142.789,146.48309999999998,149.209,153.931,155.814,158.352,160.096,163.073,166.337,170.03109999999998,172.792,176.418,179.682,181.712,183.455,186.503,190.206,192.235,194.557,196.2995,199.095,203.816,209.392,212.134,214.5735,217.293,222.378,225.425,227.748,231.374,233.118,235.6272,238.382,243.389,245.928,247.671,249.6923,252.441,257.448,260.712,263.325,266.3918,269.051,275.516,278.564,282.1884,284.924,288.411,291.898,295.385" svgx:width="0.52,0.52,0.24,0.8,0.5,0.53,0.47,0.36,0.46,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.25,0.53,0.55,0.68,0.27,0.36,0.25,0.43,0.47,0.53,0.55,0.52,0.47,0.29,0.25,0.44,0.53,0.29,0.33,0.25,0.55,0.68,0.8,0.55,0.35,0.55,0.73,0.44,0.33,0.52,0.25,0.36,0.55,0.72,0.36,0.25,0.29,0.55,0.72,0.47,0.36,0.44,0.55,0.93,0.44,0.52,0.55,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 159:</text>
   <text y="367.591" x="71.773,75.26,78.747,82.234,85.721,89.208,92.694,96.181" svgx:width="0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">733–740.</text>
   <text y="375.584" x="58.053,61.54,65.027,66.76950000000001,71.772,77.003,80.629,84.332,88.0261,89.856,93.775,95.51750000000001,97.283,101.564,104.103,105.846,109.549,113.176,114.843,117.9098,119.675,124.759,126.50150000000001,128.292,133.3,136.564,139.102,142.729,145.776,149.479,151.509,154.556,157.0652,158.904,163.117,164.8595,166.671,172.404,176.03,179.733,181.477,184.74,190.333,193.96,197.44500000000002,199.267,201.735,203.47750000000002,205.219,211.824,215.087,217.41,221.036,224.739,228.442,231.71790000000001,233.507,238.954,240.69650000000001,242.464,245.512,247.5333,249.324,252.588,254.254,255.9965,257.771,259.437,262.924,266.411,269.959,273.446,275.1188,276.875,281.882,285.369,289.072,292.559,295.097" svgx:width="0.5,0.5,0.25,0.55,0.75,0.52,0.53,0.53,0.55,0.56,0.25,0.55,0.61,0.36,0.25,0.53,0.52,0.24,0.44,0.55,0.73,0.25,0.55,0.72,0.47,0.36,0.52,0.44,0.53,0.29,0.44,0.36,0.55,0.6,0.25,0.55,0.82,0.52,0.53,0.25,0.47,0.8,0.52,0.5,0.55,0.35,0.25,0.55,0.95,0.47,0.33,0.52,0.53,0.53,0.47,0.55,0.78,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.72,0.5,0.53,0.5,0.36,0.29" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">23. Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, et al. (1992) Cohort</text>
   <text y="383.578" x="71.773,74.095,76.125,79.751,83.377,86.58319999999999,88.383,91.87,93.7519,95.527,99.23,102.856,108.449,111.713,115.4071,117.182,118.925,124.518,130.111,133.737,137.44,140.927,144.554,147.679,149.562,151.306,154.284,156.027,159.075,162.778,165.755,168.9612,170.751,173.945,175.689,178.227,181.854,184.1541,185.944,187.687,191.39,193.273,196.321,199.299,201.328,203.072,206.635,210.32909999999998,212.078,213.821,217.5151,219.277,222.904,226.168,228.197,229.941,232.988,236.692,238.721,241.0211,242.861,247.582,249.325,251.355,255.04909999999998,256.863,258.893,262.519,266.145,269.193,271.731,274.709,278.336,280.002,283.489,285.812,287.555,289.8551,291.727,293.47" svgx:width="0.33,0.29,0.52,0.52,0.46,0.55,0.5,0.27,0.55,0.53,0.52,0.8,0.47,0.53,0.55,0.25,0.8,0.8,0.52,0.53,0.5,0.52,0.44,0.27,0.25,0.43,0.25,0.44,0.53,0.43,0.46,0.55,0.46,0.25,0.36,0.52,0.33,0.55,0.25,0.53,0.27,0.44,0.43,0.29,0.25,0.5,0.53,0.55,0.25,0.53,0.55,0.52,0.47,0.29,0.25,0.44,0.53,0.29,0.33,0.55,0.68,0.25,0.29,0.53,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.25,0.53" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">study of human immunodeficiency virus infection in patients with tuberculosis in</text>
   <text y="391.515" x="71.773,77.003,80.267,82.011,84.549,88.036,91.662,93.485,95.2275,97.283,102.73,105.777,109.48,112.674,115.938,117.68050000000001,119.788,124.51,128.213,131.476,133.143,136.337,138.659,140.48,142.78009999999998,144.845,148.333,150.2149,152.329,155.376,158.64,161.179,162.845,166.0512,168.145,169.812,173.299,175.475,181.068,184.555,188.258,190.287,193.99,195.6628,197.793,203.387,206.874,209.412,211.441,214.705,216.372,218.115,220.145,223.339,225.0815,227.215,231.936,237.512,239.574,244.658,247.705,250.9112,253.01,258.094,261.142,263.464,267.09,268.834,271.3432,273.475,278.775,280.518,282.81809999999996,284.926,288.413,291.9,295.386" svgx:width="0.75,0.47,0.25,0.36,0.5,0.52,0.25,0.25,0.55,0.78,0.44,0.53,0.46,0.47,0.25,0.55,0.68,0.53,0.47,0.24,0.46,0.33,0.25,0.33,0.55,0.5,0.27,0.55,0.44,0.47,0.36,0.24,0.46,0.55,0.24,0.5,0.31,0.8,0.5,0.53,0.29,0.53,0.24,0.55,0.8,0.5,0.36,0.29,0.47,0.24,0.25,0.29,0.46,0.25,0.55,0.68,0.8,0.55,0.73,0.44,0.46,0.55,0.73,0.44,0.33,0.52,0.25,0.36,0.55,0.76,0.25,0.33,0.55,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis 146:</text>
   <text y="399.508" x="71.773,75.26,78.747,82.234,85.721,89.208,92.694,96.181" svgx:width="0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">849–854.</text>
   <text y="64.963" x="315.099,318.586,322.073,323.8155,328.818,333.1,336.803,340.067,342.605,345.869,349.133,352.327,355.6029,358.466,363.187,364.9295,367.706,371.626,373.432,377.135,379.164,382.649,385.45,389.663,391.4055,394.182,398.102,401.439,403.1815,405.974,412.4561,415.215,416.882,420.369,423.856,427.403,430.89,432.5628,435.34,441.805,443.548,445.871,451.464,454.727,458.431,461.694,465.044,468.092,473.685,476.733,480.436,482.4573,485.282,488.769,490.6509,493.446,495.475,499.102,502.728,505.776,508.314,511.292,514.918,516.688,520.175,522.497,524.241,526.5411,529.33,531.074,534.7681,537.608,540.076,543.779,547.406,549.149,552.413" svgx:width="0.5,0.5,0.25,0.55,0.61,0.53,0.47,0.36,0.47,0.47,0.46,0.47,0.55,0.68,0.25,0.55,0.56,0.25,0.53,0.29,0.5,0.55,0.6,0.25,0.55,0.56,0.47,0.25,0.55,0.93,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.93,0.25,0.33,0.8,0.47,0.53,0.47,0.47,0.44,0.8,0.44,0.53,0.29,0.55,0.5,0.27,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.25,0.53,0.55,0.35,0.53,0.52,0.25,0.47,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">24. Bhargava A, Pinto L, Pai M (2011) Mismanagement of tuberculosis in India:</text>
   <text y="73.127" x="328.819,333.826,337.09,340.716,343.039,346.086,348.49,350.2325,352.515,355.493,358.98,362.683,365.005,368.053,371.679,375.306,378.353,382.163,385.141,388.188,390.511,392.25350000000003,394.578,397.841,401.544,405.16839999999996,407.503,409.532,413.235,416.3018,418.671,423.392,426.656,429.86220000000003,432.163,434.046,437.533,440.071,444.861,448.125,450.664,454.29,456.0325,458.354,463.947,467.141,470.768,474.255,476.284,480.066,483.113,485.436,487.179,489.47909999999996,491.801,495.288,497.016,500.503,502.17,503.9125,506.2,509.248,512.735" svgx:width="0.72,0.47,0.52,0.33,0.44,0.33,0.25,0.55,0.43,0.5,0.53,0.33,0.44,0.52,0.52,0.44,0.53,0.43,0.44,0.33,0.25,0.55,0.47,0.53,0.52,0.55,0.29,0.53,0.44,0.55,0.68,0.47,0.46,0.55,0.27,0.5,0.36,0.68,0.47,0.36,0.52,0.25,0.55,0.8,0.46,0.52,0.5,0.29,0.53,0.44,0.33,0.25,0.33,0.55,0.5,0.24,0.5,0.24,0.25,0.55,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Causes, consequences, and the way forward. Hypothesis 9(1): e7.</text>
   <text y="81.46" x="315.099,318.586,322.073,323.8155,328.818,334.188,337.814,342.536,345.799,349.426,351.169,354.44489999999996,357.786,362.214,366.064,367.8065,371.165,375.084,376.827,380.53,382.56,386.045,389.362,393.574,400.039,401.7815,405.121,410.491,414.118,415.784,418.832,422.026,425.29,427.79920000000004,431.198,437.663,444.28450000000004,447.581,449.248,452.735,456.222,459.769,463.256,464.92879999999997,468.216,473.077,476.703,480.33,483.377,485.916,488.893,492.52,494.187,497.673,499.996,501.832,504.1321,507.444,513.038,516.302,520.005,523.269,526.606,529.653,535.246,538.294,541.997,544.0183,547.354,550.98" svgx:width="0.5,0.5,0.25,0.55,0.77,0.52,0.68,0.47,0.52,0.25,0.47,0.55,0.63,0.55,0.25,0.55,0.56,0.25,0.53,0.29,0.5,0.55,0.6,0.93,0.25,0.55,0.77,0.52,0.24,0.44,0.46,0.47,0.36,0.55,0.93,0.95,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.8,0.47,0.53,0.47,0.47,0.44,0.8,0.44,0.53,0.29,0.55,0.52,0.46" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">25. Udwadia ZF, Pinto LM, Uplekar MW (2010) Tuberculosis management by</text>
   <text y="89.681" x="328.819,332.445,334.984,336.727,339.921,343.185,345.214,348.2808,350.758,354.384,356.923,360.186,363.164,365.27,367.013,369.042,370.786,374.273,377.976,381.023,383.562,385.8621,388.342,390.085,393.77909999999997,396.279,402.743,406.37,411.963,415.589,418.853,420.596,422.3385,424.849,427.318,431.021,434.648,436.391,439.655,441.3975,443.897,447.6,450.864,453.16409999999996,455.632,458.896,462.599,465.793,467.822,471.525,473.269,476.972,480.24789999999996,482.729,485.707,489.41,492.674,496.448,499.712,502.759,506.3834,508.864,510.607,514.3011,516.744,518.773,523.495,526.98,529.442,533.07,536.117,539.095,542.359,545.985,549.114,551.436" svgx:width="0.52,0.36,0.25,0.46,0.47,0.29,0.44,0.55,0.52,0.36,0.47,0.43,0.29,0.25,0.29,0.25,0.5,0.53,0.44,0.36,0.33,0.55,0.25,0.53,0.55,0.93,0.52,0.8,0.52,0.47,0.25,0.25,0.55,0.35,0.53,0.52,0.25,0.47,0.25,0.55,0.53,0.47,0.33,0.55,0.47,0.53,0.46,0.29,0.53,0.25,0.53,0.47,0.55,0.43,0.53,0.47,0.53,0.47,0.44,0.52,0.55,0.25,0.53,0.55,0.29,0.68,0.5,0.55,0.52,0.44,0.43,0.47,0.52,0.44,0.33,0.4" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">private practitioners in Mumbai, India: has anything changed in two decades?</text>
   <text y="97.844" x="328.819,332.738,336.95,340.437,344.2008,346.562,352.296,355.999,359.0658,361.416,364.903,366.6455,368.956,372.004,375.49,378.977,382.464,386.019,389.506" svgx:width="0.56,0.6,0.5,0.54,0.55,0.82,0.53,0.44,0.55,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">PLoS One 5: e12023.</text>
   <text y="106.178" x="315.099,318.586,322.073,323.8155,328.818,333.54,336.804,339.342,342.606,347.327,350.591,352.2638,354.215,359.516,361.2585,363.229,368.599,372.225,376.946,380.21,383.837,385.58,388.85589999999996,390.836,395.265,399.114,400.8565,402.798,407.882,411.368,414.995,417.533,419.277,422.54,426.167,429.214,432.2111,434.203,439.21,440.9525,442.876,449.341,452.388,456.091,458.121,461.39689999999996,463.341,468.0806,469.973,471.64,475.189,478.676,482.163,485.65,487.3228,489.248,491.716,495.419,498.397,500.936,503.983,507.247,509.569,511.313,515.016,518.2918999999999,520.256,521.999,525.702,528.68,530.424,534.05,537.098,540.801,543.779,546.8457999999999,548.827,552.314" svgx:width="0.5,0.5,0.25,0.55,0.68,0.47,0.36,0.47,0.68,0.47,0.24,0.55,0.76,0.25,0.55,0.77,0.52,0.68,0.47,0.52,0.25,0.47,0.55,0.63,0.55,0.25,0.55,0.73,0.5,0.52,0.36,0.25,0.47,0.52,0.44,0.43,0.55,0.72,0.25,0.55,0.93,0.44,0.53,0.29,0.47,0.55,0.68,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.35,0.53,0.43,0.36,0.44,0.47,0.33,0.25,0.53,0.47,0.55,0.25,0.53,0.43,0.25,0.52,0.44,0.53,0.43,0.44,0.55,0.5,0.27" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">26. Agrawal D, Udwadia ZF, Rodriguez C, Mehta A (2009) Increasing incidence of</text>
   <text y="114.342" x="328.819,330.783,332.532,336.273,339.845,342.465,346.034,349.775,353.517,355.331,359.115,362.684,364.432,368.06,371.845,374.974,377.232,379.896,383.026,385.464,387.289,389.727,391.838,395.183,398.968,400.9893,405.828,412.404,415.692,418.752,422.38,426.006,429.466,432.526,434.637,437.812,440.419,442.244,445.986,451.562,456.417,458.571,462.198,465.998,469.128,471.792,474.852,478.593,480.341,483.91,486.348,488.162,490.46209999999996,495.305,497.119,500.8131,505.679,512.256,515.883,521.667,525.408,528.753,530.578,532.3204999999999,537.154,539.704,543.489,547.231,549.044,552.446" svgx:width="0.27,0.24,0.52,0.5,0.36,0.5,0.52,0.52,0.25,0.53,0.5,0.24,0.5,0.53,0.44,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.93,0.46,0.43,0.5,0.52,0.47,0.43,0.29,0.44,0.36,0.25,0.52,0.8,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.25,0.53,0.55,0.93,0.52,0.8,0.52,0.47,0.25,0.25,0.55,0.35,0.53,0.52,0.25,0.47,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.</text>
   <text y="122.505" x="328.819,331.288,334.991,337.0123,339.363,341.8025,344.182,349.043,352.669,356.296,359.343,361.882,364.8791,367.198,371.41,375.036,378.74,382.0159,384.375,389.676,391.419,393.71909999999997,396.111,399.597,403.084,404.751,408.238,409.905,411.6475,413.968,417.455,420.941,424.428,427.915,431.402" svgx:width="0.35,0.53,0.29,0.55,0.35,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.55,0.6,0.52,0.53,0.47,0.55,0.76,0.25,0.33,0.55,0.5,0.5,0.24,0.5,0.24,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Int J Tuberc Lung Dis 13(1): 79–83.</text>
   <text y="130.896" x="315.099,318.586,322.073,323.8155,328.818,333.826,337.313,340.6586,342.368,347.961,351.734,353.4765,355.123,360.569,363.833,365.5,368.987,372.6811,374.397,378.17,379.9125,381.597,386.318,387.985,389.651,392.915,398.508,402.135,404.673,407.937,409.966,413.453,416.743,420.0189,421.676,425.449,427.1915,428.876,432.65,434.393,437.371,440.635,442.378,444.917,447.9838,449.682,454.766,456.5085,458.129,462.989,464.733,467.996,471.337,474.5432,476.212,480.641,485.871,487.6135,489.251,492.298,494.3193,495.997,499.261,500.927,502.6695,504.387,506.054,509.541,513.028,516.515,520.001,521.6738,523.378,529.842,533.469,535.135,537.165,538.908,542.535,545.073,548.699,551.963" svgx:width="0.5,0.5,0.25,0.55,0.72,0.5,0.48,0.55,0.8,0.54,0.25,0.55,0.78,0.47,0.24,0.5,0.53,0.55,0.54,0.25,0.55,0.68,0.24,0.24,0.47,0.8,0.52,0.36,0.47,0.29,0.5,0.46,0.47,0.55,0.54,0.25,0.55,0.54,0.25,0.43,0.47,0.25,0.36,0.44,0.55,0.73,0.25,0.55,0.7,0.25,0.47,0.47,0.46,0.55,0.63,0.75,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.93,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">27. Cox HS, Kalon S, Allamuratova S, Sizaire V, Tigay ZN, et al. (2007) Multidrug-</text>
   <text y="139.06" x="328.819,333.903,336.95,339.273,341.016,343.338,345.368,348.631,352.335,354.3563,357.787,362.648,366.348,369.974,373.022,375.56,378.538,382.164,383.831,387.318,389.64,391.384,393.6841,397.129,401.99,404.529,407.576,410.84,412.869,418.462,421.51,425.303,427.3243,430.689,436.423,440.049,442.078,445.056,448.543,454.216,457.264,459.5641,462.947,464.69,468.3841,471.791,477.238,480.502,483.04,486.304,489.498,492.762,494.523,498.15,501.413,504.607,506.93,508.959,512.223,515.926,517.6685,521.11,526.481,529.458,533.085,536.132,539.326,541.07,543.392,545.422,548.685,552.388" svgx:width="0.73,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.7,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.82,0.52,0.29,0.43,0.5,0.8,0.44,0.33,0.55,0.25,0.53,0.55,0.78,0.47,0.36,0.47,0.46,0.47,0.24,0.52,0.47,0.46,0.33,0.29,0.47,0.53,0.25,0.55,0.77,0.43,0.52,0.44,0.46,0.25,0.33,0.29,0.47,0.53,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan:</text>
   <text y="147.223" x="328.819,333.68,336.218,339.266,342.529,344.559,350.152,353.199,356.993,359.0143,361.585,366.593,370.08,375.673,379.3,380.966,384.014,387.354,389.098,391.127,394.33320000000003,396.959,400.223,403.926,407.55039999999997,410.111,415.481,420.781,425.865,428.041,432.902,437.15369999999996,439.816,443.08,448.673,452.16,455.863,459.1389,461.698,466.559,469.098,472.145,475.409,477.438,483.031,486.079,489.873,491.8943,494.465,498.315,501.579,503.322,504.989,508.615,511.154,514.201,516.524,518.2665,520.882,524.802,529.014,532.501,536.2647999999999,538.853,544.586,549.816" svgx:width="0.7,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.72,0.5,0.8,0.52,0.24,0.44,0.48,0.25,0.29,0.46,0.55,0.47,0.53,0.52,0.55,0.77,0.76,0.73,0.31,0.7,0.61,0.55,0.47,0.8,0.5,0.53,0.47,0.55,0.7,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.55,0.47,0.25,0.24,0.52,0.36,0.44,0.33,0.25,0.55,0.56,0.6,0.5,0.54,0.55,0.82,0.75,0.63" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Treatment Complexity and XDR-TB among Treatment Failures. PLoS ONE</text>
   <text y="155.387" x="328.819,332.306,333.973,337.46,340.946,342.613,344.3555,346.733,349.78,353.267,356.754,360.241,363.728" svgx:width="0.5,0.24,0.5,0.5,0.24,0.25,0.55,0.44,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">2(11): e1126.</text>
   <text y="163.777" x="315.099,318.586,322.073,323.8155,328.818,331.287,333.609,336.873,340.137,343.331,345.074,348.701,350.444,352.7441,354.554,358.474,360.2165,361.981,367.065,370.328,373.592,377.218,380.266,383.969,387.32,390.946,394.5704,396.334,402.798,407.157,408.8995,410.619,415.48,418.5468,420.314,425.398,427.14050000000003,428.874,433.735,436.273,439.537,442.7432,444.52,449.528,453.301,455.0435,456.822,461.544,464.738,468.001,471.486,473.262,478.709,480.4515,482.219,485.267,487.2883,489.022,492.286,493.953,495.6955,497.469,499.136,502.623,506.11,509.596,513.083,514.7558,516.517,522.11,523.853,527.117,530.8111,532.616,534.939,538.565,541.103,544.297,546.041,549.235,552.499" svgx:width="0.5,0.5,0.25,0.55,0.35,0.33,0.47,0.47,0.46,0.25,0.52,0.25,0.33,0.55,0.56,0.25,0.55,0.73,0.47,0.47,0.52,0.44,0.53,0.47,0.52,0.52,0.55,0.93,0.63,0.25,0.55,0.7,0.44,0.55,0.73,0.25,0.55,0.7,0.36,0.47,0.46,0.55,0.72,0.54,0.25,0.55,0.68,0.46,0.47,0.5,0.55,0.78,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.8,0.25,0.47,0.53,0.55,0.33,0.52,0.36,0.46,0.25,0.46,0.47,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">28. Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K, et al. (2010) High survival</text>
   <text y="171.94" x="328.819,332.083,335.786,339.4104,341.801,343.83,346.368,349.416,352.68,354.709,360.395,363.442,367.146,369.1673,371.563,373.885,377.511,380.489,383.467,386.515,388.837,391.1371,393.558,395.88,399.507,401.829,403.932,407.196,408.939,412.643,415.69,419.3144,421.733,424.997,426.88,428.909,431.956,434.46520000000004,436.925,438.955,443.676,447.161,449.567,452.831,456.534,460.1584,462.549,464.579,468.282,470.82,473.868,476.9348,479.329,482.523,485.571,488.835,491.373,493.6731,496.109,499.596,501.4779,503.876,505.759,507.502,510.041,512.363,514.392,516.568,518.235,519.978,523.773,526.8398,529.216,533.937,539.021,543.9,546.279,548.162,551.649" svgx:width="0.47,0.53,0.52,0.55,0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.33,0.52,0.43,0.43,0.44,0.33,0.33,0.55,0.33,0.52,0.33,0.29,0.47,0.25,0.53,0.44,0.52,0.55,0.47,0.27,0.29,0.44,0.36,0.55,0.29,0.68,0.5,0.55,0.47,0.53,0.52,0.55,0.29,0.53,0.36,0.44,0.44,0.55,0.46,0.44,0.47,0.36,0.33,0.55,0.5,0.27,0.55,0.27,0.25,0.36,0.33,0.29,0.31,0.24,0.25,0.53,0.44,0.55,0.68,0.73,0.7,0.55,0.27,0.5,0.36" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">and treatment success sustained after two and three years of first-line ART for</text>
   <text y="180.104" x="328.819,331.797,335.5,337.243,338.91,342.536,345.075,348.122,351.8161,354.215,355.959,359.6531,361.982,366.989,370.253,375.846,379.472,382.959,386.586,388.329,391.686,393.4285,395.712,398.18,401.667,405.294,407.9,411.603,414.867,416.5398,418.841,422.328,424.20989999999995,426.551,428.581,432.284,435.3508,437.719,440.188,443.891,445.92,448.968,451.506,455.209,458.473,460.502,462.246,465.733,469.521,472.785,474.4578,476.777,481.499,483.968,489.268,493.0318,495.372,499.146,502.633,505.61,507.354,510.401,512.431,515.6372,517.992,521.479,524.965,526.7075,529.046,532.533,536.02" svgx:width="0.43,0.53,0.25,0.24,0.52,0.36,0.44,0.53,0.55,0.25,0.53,0.55,0.72,0.47,0.8,0.52,0.5,0.52,0.25,0.47,0.25,0.55,0.35,0.5,0.52,0.36,0.53,0.47,0.24,0.55,0.5,0.27,0.55,0.29,0.53,0.44,0.55,0.35,0.53,0.29,0.44,0.36,0.53,0.47,0.29,0.25,0.5,0.53,0.47,0.24,0.55,0.68,0.35,0.76,0.54,0.55,0.54,0.5,0.43,0.25,0.44,0.29,0.46,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">children in Cambodia. Journal of the International AIDS Society 13: 11.</text>
   <text y="188.495" x="315.099,318.586,322.073,323.8155,328.818,333.903,337.167,340.43,344.057,347.104,350.807,354.158,357.785,361.4094,365.099,371.564,375.923,377.6655,381.369,383.838,386.16,389.424,392.764,395.958,397.701,401.328,403.071,405.3711,409.09,413.009,414.7515,418.444,422.872,426.136,429.114,432.9,436.164,438.702,440.446,443.709,447.4031,451.097,456.181,457.9235,461.642,466.503,469.5698,473.264,478.348,480.0905,483.808,487.581,491.068,494.182,497.809,501.512,504.7879,508.468,512.241,513.9834999999999,517.709,520.757,522.7783,526.496,529.76,531.427,533.1695,536.87,538.537,542.024,545.511,549.058,552.545" svgx:width="0.5,0.5,0.25,0.55,0.73,0.47,0.47,0.52,0.44,0.53,0.47,0.52,0.52,0.55,0.93,0.63,0.25,0.55,0.35,0.33,0.47,0.47,0.46,0.25,0.52,0.25,0.33,0.55,0.56,0.25,0.55,0.63,0.47,0.43,0.53,0.47,0.36,0.25,0.47,0.53,0.55,0.73,0.25,0.55,0.7,0.44,0.55,0.73,0.25,0.55,0.54,0.5,0.44,0.52,0.53,0.47,0.55,0.54,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">29. Raguenaud ME, Isaakidis P, Zachariah R, Te V, Soeung S, et al. (2009)</text>
   <text y="196.658" x="328.819,333.178,336.518,339.496,342.543,344.21,345.877,349.0,352.703,354.72429999999997,356.653,360.14,363.766,365.795,368.841,372.328,377.921,380.968,383.2681,385.224,388.488,394.081,397.639,401.342,404.61789999999996,406.54,412.134,414.602" svgx:width="0.63,0.48,0.43,0.44,0.24,0.24,0.44,0.53,0.29,0.55,0.5,0.52,0.29,0.43,0.5,0.8,0.44,0.33,0.55,0.47,0.8,0.5,0.53,0.47,0.55,0.8,0.35,0.73" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Excellent outcomes among HIV</text>
   <text y="196.658" x="419.698" svgx:width="0.55" style="fill:rgb(0,0,0);font-family:AdvP697C;font-size:6.97px;stroke:none;">+</text>
   <text y="196.658" x="425.537,428.515,432.218,433.962,435.628,439.255,441.793,444.841,448.5351,450.537,454.024,457.7181,459.664,464.385,469.529,474.389,476.1315,478.089,481.715,485.342,487.3633,489.313,492.94,496.643,499.906,502.884,505.862,508.984,512.611,514.64,517.904,521.53,523.197,526.4032,528.372,532.075,533.819,537.082,540.7761,542.771,546.397,548.936,551.983" svgx:width="0.43,0.53,0.25,0.24,0.52,0.36,0.44,0.53,0.55,0.5,0.53,0.55,0.68,0.73,0.7,0.25,0.55,0.52,0.52,0.29,0.55,0.52,0.53,0.47,0.43,0.43,0.44,0.52,0.29,0.47,0.52,0.24,0.46,0.55,0.53,0.25,0.47,0.53,0.55,0.52,0.36,0.44,0.31" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">children on ART, but unacceptably high pre-</text>
   <text y="204.822" x="328.819,333.54,338.624,343.50300000000004,346.109,351.702,355.189,357.727,359.757,363.021,364.687,366.431,368.46,371.6662,374.283,377.547,381.25,384.8744,387.492,389.159,392.646,394.968,397.29,400.338,402.6381,405.293,407.322,410.807,413.4,415.283,418.77,420.437,422.103,425.59,430.311,432.56,436.187,439.813,441.5555,444.125,447.4009,450.021,452.999,456.486,460.189,463.676,466.215,468.23629999999997,470.826,473.149,475.178,478.876,482.503,485.7092,488.287,490.17,492.708,496.195,501.771,504.386,509.394,512.657,518.25,521.877,525.364,528.99,530.734,534.091,535.8335,538.399,542.681,549.146" svgx:width="0.68,0.73,0.7,0.55,0.8,0.5,0.36,0.29,0.47,0.24,0.25,0.29,0.46,0.55,0.47,0.53,0.52,0.55,0.24,0.5,0.33,0.33,0.44,0.33,0.55,0.29,0.5,0.55,0.27,0.5,0.24,0.24,0.5,0.68,0.31,0.52,0.52,0.25,0.55,0.47,0.55,0.43,0.5,0.53,0.5,0.36,0.29,0.55,0.33,0.29,0.52,0.52,0.46,0.55,0.27,0.36,0.5,0.8,0.55,0.72,0.47,0.8,0.52,0.5,0.52,0.25,0.47,0.25,0.55,0.61,0.93,0.72" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">ART mortality and losses to follow-up: a cohort study from Cambodia. BMC</text>
   <text y="212.985" x="328.819,332.738,335.786,339.412,341.156,344.419,346.449,348.95820000000003,351.381,354.868,356.6105,358.921,362.408,365.895" svgx:width="0.56,0.44,0.52,0.25,0.47,0.29,0.36,0.55,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Pediatr 9: 54.</text>
   <text y="221.376" x="315.099,318.586,322.073,323.8155,328.818,335.423,338.91,341.449,343.115,346.7394,349.454,355.047,358.094,361.358,363.025,365.054,368.74809999999997,371.449,377.182,379.72,382.984,386.247,389.951,391.694,394.672,397.936,399.965,401.708,405.195,408.8891,411.585,413.251,419.856,425.53,431.263,432.9358,435.565,437.232,440.719,444.205,447.692,451.179,452.85179999999997,455.519,461.984,465.248,468.951,472.215,475.479,478.526,484.204,487.252,490.955,492.9763,495.655,499.142,501.02389999999997,503.649,510.113,515.414,520.497,522.673,527.534,531.816,533.5585,536.301,539.5769,542.197,544.08,545.824,548.871,550.538" svgx:width="0.5,0.5,0.25,0.55,0.95,0.5,0.36,0.24,0.52,0.55,0.8,0.44,0.47,0.24,0.29,0.53,0.55,0.82,0.36,0.47,0.47,0.53,0.25,0.43,0.47,0.29,0.25,0.5,0.53,0.55,0.24,0.95,0.8,0.82,0.24,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.93,0.47,0.53,0.47,0.47,0.44,0.8,0.44,0.53,0.29,0.55,0.5,0.27,0.55,0.93,0.76,0.73,0.31,0.7,0.61,0.25,0.55,0.47,0.55,0.27,0.25,0.44,0.24,0.52" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">30. World Health Organization (WHO) (2009) Management of MDR-TB: a field</text>
   <text y="229.54" x="328.819,332.083,335.709,337.452,341.079,344.126,345.8685,348.773,353.5126,356.427,359.405,362.892,368.484,372.111,375.375,379.078,380.821,384.308,388.0021,390.95,394.576,398.063,401.041,404.667,410.26,413.308,417.011,419.0323,421.958,423.988,427.473,430.405,435.775,439.402,441.145,444.772,447.819,449.486,451.229,454.932,458.069,460.3691,463.285,465.168,468.655,471.1642,474.056,476.085,479.788,482.8548,485.734,489.654,492.193,495.68,498.943,501.482,504.839,510.432,516.025,519.289,521.318,523.062,526.0591000000001,528.931,535.396,538.66,542.363,545.711,548.975,552.022" svgx:width="0.47,0.52,0.25,0.52,0.44,0.25,0.55,0.68,0.55,0.43,0.5,0.8,0.52,0.47,0.53,0.25,0.5,0.53,0.55,0.52,0.5,0.43,0.52,0.8,0.44,0.53,0.29,0.55,0.29,0.5,0.55,0.77,0.52,0.25,0.52,0.44,0.24,0.25,0.53,0.44,0.33,0.55,0.27,0.5,0.36,0.55,0.29,0.53,0.44,0.55,0.56,0.36,0.5,0.47,0.36,0.47,0.8,0.8,0.47,0.29,0.25,0.43,0.55,0.93,0.47,0.53,0.47,0.47,0.44,0.31" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">guide. A companion document to Guidelines for the Programmatic Manage-</text>
   <text y="237.703" x="328.819,334.412,337.459,341.163,343.1843,345.542,349.029,350.91089999999997,353.252,358.552,361.091,364.717,367.981,370.157,372.695,375.743,378.065,379.896,382.218,384.247,387.511,391.214,393.2353,395.599,400.459,404.086,407.712,410.76,413.298,416.276,419.902,421.569,425.056,427.378,429.214,431.5141,433.863,435.53,442.134,447.727,453.459,457.086,462.679,467.54,474.112,477.738,482.599,486.881,490.507,493.994,497.481,500.968,504.455,506.198,509.685,513.172,516.741,520.005,521.672,523.4145,525.755,531.125,534.172,537.875,540.923,544.117,547.38" svgx:width="0.8,0.44,0.53,0.29,0.55,0.5,0.27,0.55,0.76,0.36,0.52,0.47,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.24,0.95,0.8,0.82,0.52,0.8,0.7,0.93,0.52,0.7,0.61,0.52,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.47,0.24,0.25,0.55,0.77,0.44,0.53,0.44,0.46,0.47,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">ment of Drug-resistant Tuberculosis (WHO/HTM/TB/2008.402a). Geneva.</text>
   <text y="246.093" x="315.099,318.586,322.073,323.8155,328.818,333.101,336.588,339.635,343.338,349.0,352.0668,354.216,359.223,364.231,365.9735,368.218,373.449,376.712,380.339,383.386,385.416,388.6919,390.893,394.813,396.5555,398.773,404.366,406.11,407.776,409.443,412.491,418.084,421.347,425.133,428.8271,431.03,436.331,438.0735,440.271,445.502,447.245,450.223,453.71,455.3828,457.618,464.083,468.002,469.7445,471.96,475.733,479.436,482.484,486.187,489.451,491.19350000000003,493.389,497.162,498.9045,501.156,504.203,506.22429999999997,508.412,511.676,513.342,515.0844999999999,517.312,518.979,522.466,525.953,529.44,532.927,534.5998000000001,536.813,541.898,545.162,548.788,550.531" svgx:width="0.5,0.5,0.25,0.55,0.61,0.5,0.44,0.53,0.8,0.44,0.55,0.72,0.72,0.25,0.55,0.75,0.47,0.52,0.44,0.29,0.47,0.55,0.56,0.25,0.55,0.8,0.25,0.24,0.24,0.44,0.8,0.47,0.53,0.53,0.55,0.76,0.25,0.55,0.75,0.25,0.43,0.5,0.24,0.55,0.93,0.56,0.25,0.55,0.54,0.53,0.44,0.53,0.47,0.25,0.55,0.54,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.73,0.47,0.52,0.25,0.52" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">31. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid</text>
   <text y="254.257" x="328.819,334.412,337.899,339.566,342.613,345.591,349.217,350.884,354.148,356.65720000000005,360.338,363.964,367.012,369.041,372.089,375.066,377.096,378.839,382.326,386.0201,389.646,393.133,395.01489999999995,398.603,400.632,404.259,407.885,410.933,413.471,416.449,420.075,421.742,425.229,427.551,429.295,431.5951,435.28,438.544,442.247,445.8714,449.452,451.991,453.734,455.617,458.881,464.474,468.1,469.844,473.5381,477.173,479.712,482.759,485.082,486.825,489.147,491.177,494.52,498.223,501.201,504.248,505.9905,509.599,514.8265,518.387,522.746,526.449,529.712,531.3848,534.997,537.4364999999999,541.006,547.471,550.519" svgx:width="0.8,0.5,0.24,0.44,0.43,0.52,0.24,0.47,0.36,0.55,0.52,0.44,0.29,0.44,0.43,0.29,0.25,0.5,0.53,0.55,0.5,0.27,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.47,0.53,0.52,0.55,0.36,0.25,0.27,0.47,0.8,0.52,0.25,0.53,0.55,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.43,0.44,0.25,0.55,0.75,0.55,0.63,0.53,0.47,0.24,0.55,0.35,0.55,0.93,0.44,0.52" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">molecular detection of tuberculosis and rifampin resistance. N Engl J Med</text>
   <text y="262.42" x="328.819,332.306,335.793,339.28,340.946,344.433,347.979,349.646,351.3885,353.705,357.192,360.679,364.166,367.653,371.14,374.626,378.113" svgx:width="0.5,0.5,0.5,0.24,0.5,0.5,0.24,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">363(11): 1005–15.</text>
   <text y="270.754" x="315.099,318.586,322.073,323.8155,328.818,335.423,338.91,341.449,343.115,346.7394,350.361,355.954,359.002,362.265,363.932,365.961,369.6551,373.264,378.996,381.535,384.798,388.062,391.765,393.509,396.486,399.75,401.78,403.523,407.106,410.8001,414.363,416.03,422.634,428.227,433.96,435.6328,439.249,440.916,444.403,447.89,451.377,454.864,456.53679999999997,460.111,465.195,468.681,471.945,475.572,481.165,484.428,488.0524,491.629,493.512,496.999,499.50820000000004,503.138,505.676,509.163,510.83,512.496,514.24,517.943,521.2189,524.793,528.279,531.906,533.9273,537.548,542.917,546.544,549.591,552.13" svgx:width="0.5,0.5,0.25,0.55,0.95,0.5,0.36,0.24,0.52,0.55,0.8,0.44,0.47,0.24,0.29,0.53,0.55,0.82,0.36,0.47,0.47,0.53,0.25,0.43,0.47,0.29,0.25,0.5,0.53,0.55,0.24,0.95,0.8,0.82,0.24,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.73,0.5,0.47,0.52,0.8,0.47,0.52,0.55,0.27,0.5,0.36,0.55,0.36,0.5,0.24,0.24,0.25,0.53,0.47,0.55,0.5,0.52,0.29,0.55,0.77,0.52,0.44,0.36,0.29" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">32. World Health Organization (WHO) (2010) Roadmap for rolling out Xpert</text>
   <text y="278.918" x="328.819,335.284,340.144,344.426,348.053,353.137,355.689,359.52250000000004,361.472,363.355,366.842,369.3512,371.335,373.874,377.138,380.764,382.507,386.1314,388.115,391.741,393.485,396.749,400.012,403.715,407.202,409.525,411.268,413.56809999999996,415.552,419.039,420.92089999999996,422.865,427.726,431.9777,433.976,437.24,440.943,444.56739999999996,446.561,453.026,458.326,463.41,465.586,470.446,474.728,476.4705,478.477,483.846,486.894,490.597,493.645,496.839,500.102,501.8445,503.816,508.537,511.731,514.995,516.738,518.405,521.669,525.295,526.962,530.01,531.7524999999999,533.748,537.451,539.481,541.51,545.136,546.88,550.585" svgx:width="0.93,0.7,0.61,0.52,0.73,0.35,0.55,0.55,0.27,0.5,0.36,0.55,0.36,0.47,0.52,0.25,0.52,0.55,0.52,0.25,0.47,0.47,0.53,0.5,0.33,0.25,0.33,0.55,0.5,0.27,0.55,0.7,0.61,0.55,0.47,0.53,0.52,0.55,0.93,0.76,0.73,0.31,0.7,0.61,0.25,0.55,0.77,0.44,0.53,0.44,0.46,0.47,0.25,0.55,0.68,0.46,0.47,0.25,0.24,0.47,0.52,0.24,0.44,0.25,0.55,0.53,0.29,0.29,0.52,0.25,0.52,0.52" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">MTB/RIF for rapid diagnosis of TB and MDR-TB. Geneva, Available: http://</text>
   <text y="287.138" x="328.819,333.636,338.453,343.269,345.108,349.925,353.724,357.352,359.191,361.03,364.829,366.954,370.676,372.801,376.522,380.244,382.007,385.366,389.088,392.67,395.304,398.664,400.788,404.371,407.005,410.294,414.016,416.65,420.233,423.592,427.314,433.003,436.404,440.031,443.735,447.137,450.879,454.023,456.658,458.785,462.413,468.103,470.229,473.857,476.182,478.818,480.658,482.638,484.478,488.105,491.905,493.885,495.6275,500.462,505.28,508.355,511.429,514.574,516.993,519.315,522.548,526.1724,530.996,534.579,538.064,542.913,545.479,549.202,550.966" svgx:width="0.68,0.68,0.68,0.25,0.68,0.53,0.5,0.25,0.25,0.53,0.29,0.52,0.29,0.52,0.52,0.24,0.47,0.52,0.5,0.36,0.47,0.29,0.5,0.36,0.46,0.52,0.36,0.5,0.47,0.52,0.8,0.47,0.52,0.5,0.48,0.52,0.44,0.36,0.29,0.5,0.8,0.29,0.52,0.31,0.36,0.25,0.27,0.25,0.52,0.52,0.27,0.25,0.55,0.68,0.43,0.43,0.44,0.33,0.33,0.44,0.52,0.55,0.5,0.5,0.55,0.35,0.52,0.24,0.46" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">www.who.int/tb/laboratory/roadmap_xpert_mtb-rif.pdf. Accessed 10 July</text>
   <text y="295.302" x="328.819,332.306,335.793,339.28,342.767" svgx:width="0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">2011.</text>
   <text y="303.635" x="315.099,318.587,322.075,323.8175,328.82,333.904,337.169,340.796,345.518,348.782,350.5245,352.406,357.49,359.2325,361.08,365.362,368.85,371.898,375.602,381.196,384.2628,386.083,391.091,392.8335,394.7,399.931,403.196,406.823,409.871,411.901,415.1769,417.039,420.959,422.7015,424.522,428.296,432.0,435.048,437.078,439.108,442.3142,444.197,448.919,450.6615,452.474,457.196,458.864,460.531,463.795,467.499,471.1234,472.999,478.3,480.0425,481.899,484.947,486.9683,488.815,492.08,493.747,495.4895,497.32,498.987,502.475,505.963,509.45,512.938,514.6108,516.484,521.854,525.482,528.53,531.069,533.0903,534.967,541.433,546.294,550.577" svgx:width="0.5,0.5,0.25,0.55,0.73,0.47,0.52,0.68,0.47,0.25,0.55,0.73,0.25,0.55,0.61,0.5,0.44,0.53,0.8,0.44,0.55,0.72,0.25,0.55,0.75,0.47,0.52,0.44,0.29,0.47,0.55,0.56,0.25,0.55,0.54,0.53,0.44,0.29,0.29,0.46,0.55,0.68,0.25,0.55,0.68,0.24,0.24,0.47,0.53,0.52,0.55,0.76,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.77,0.52,0.44,0.36,0.29,0.55,0.93,0.7,0.61,0.52" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">33. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, et al. (2011) Xpert MTB/</text>
   <text y="311.799" x="328.819,333.903,336.372,340.221,341.9635,346.336,349.6119,353.932,359.163,362.211,366.9506,371.28,375.2,376.943,378.61,380.277,383.54,386.04920000000004,390.442,392.185,395.8791,400.249,405.55,407.293,410.557,413.82,417.596,421.083,423.405,425.149,427.4491,431.825,435.312,437.1939,441.52,445.878,449.219,451.248,453.787,457.05,460.677,464.303,466.065,471.658,475.145,478.848,482.112,484.651,487.85720000000003,492.199,497.06,500.686,504.313,507.36,509.898,512.876,516.503,518.169,521.656,523.979,525.815,528.137,530.925,535.226,537.6655,542.029,547.037,548.704,550.447" svgx:width="0.73,0.35,0.55,0.25,0.55,0.47,0.55,0.75,0.44,0.68,0.55,0.56,0.25,0.24,0.24,0.47,0.36,0.55,0.25,0.53,0.55,0.76,0.25,0.47,0.47,0.53,0.5,0.33,0.25,0.33,0.55,0.5,0.27,0.55,0.63,0.48,0.29,0.36,0.47,0.52,0.52,0.24,0.8,0.5,0.53,0.47,0.36,0.46,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.4,0.55,0.35,0.55,0.72,0.24,0.25,0.53" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis? J Clin</text>
   <text y="319.963" x="328.819,335.284,337.027,340.005,342.543,346.03,349.657,351.4,354.887,356.5598,358.921,362.408,365.894,367.6365,369.975,373.462,376.949,380.436,383.922,387.409,390.896,394.383,397.87,401.436" svgx:width="0.93,0.25,0.43,0.36,0.5,0.52,0.25,0.5,0.24,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Microbiol 49: 2540–2545.</text>
   <text y="328.353" x="315.099,318.586,322.073,323.8155,328.818,332.592,336.295,338.038,341.7321,344.578,348.351,350.0935,352.912,356.762,360.452,362.991,364.734,368.4281,371.28,373.749,375.49150000000003,378.31,382.592,385.856,389.05,392.536,396.24,399.5159,402.346,404.815,406.5575,409.375,415.841,419.105,421.134,424.2008,427.063,432.51,434.2525,437.097,442.543,444.287,449.863,452.687,455.156,459.877,461.6195,464.478,467.526,469.5473,472.415,475.679,477.345,479.08750000000003,481.882,483.549,487.036,490.522,494.07,497.557,499.2298,502.063,507.071,510.558,516.151,521.744,525.37,529.073,530.816,532.846,536.04,538.216,541.842,545.203,547.525,550.573" svgx:width="0.5,0.5,0.25,0.55,0.54,0.53,0.25,0.53,0.55,0.54,0.25,0.55,0.55,0.52,0.36,0.25,0.53,0.55,0.35,0.25,0.55,0.61,0.47,0.46,0.5,0.53,0.47,0.55,0.35,0.25,0.55,0.93,0.47,0.29,0.44,0.55,0.78,0.25,0.55,0.78,0.25,0.8,0.55,0.35,0.68,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24,0.55,0.72,0.5,0.8,0.8,0.52,0.53,0.25,0.29,0.46,0.31,0.52,0.47,0.33,0.44,0.52" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">34. Shin S, Furin J, Bayona J, Mate K, Kim JY, et al. (2004) Community-based</text>
   <text y="336.517" x="328.819,330.917,333.525,336.643,339.987,342.085,347.754,350.872,354.671,356.6923,361.474,364.961,366.8429,371.678,377.347,380.974,382.79,384.888,386.701,390.329,392.995,396.622,400.025,402.293,404.901,408.019,410.341,412.214,414.536,416.692,420.037,423.835,425.8563,430.638,432.736,436.362,440.106,443.224,445.832,448.894,452.521,454.337,457.909,460.231,462.103,464.4031,469.19,471.004,474.6981,479.508,483.721,485.574,491.243,494.588,496.33050000000003,501.108,505.028,508.252,510.86,514.487,516.2294999999999,521.065,524.5500000000001,529.342,532.536,535.692,539.036,541.645,543.9451,548.731,552.303" svgx:width="0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.5,0.27,0.55,0.8,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.25,0.53,0.55,0.6,0.25,0.8,0.47,0.25,0.55,0.56,0.44,0.36,0.52,0.25,0.55,0.5,0.55,0.46,0.44,0.47,0.36,0.33,0.55,0.5,0.27" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of</text>
   <text y="344.681" x="328.819,331.866,335.207,338.833,341.881,344.419,346.163,349.21,352.913,355.973,359.02,360.7625,363.059,366.832,370.319,373.3161,375.645,379.417,382.395,384.1375,386.472,392.937,396.053,399.6774,402.006,405.493,408.98,410.7225,413.06,416.547,420.034,423.521,427.008,430.495,433.982,437.469,440.956,444.442" svgx:width="0.44,0.48,0.52,0.44,0.36,0.25,0.44,0.53,0.43,0.44,0.25,0.55,0.54,0.5,0.43,0.55,0.54,0.43,0.25,0.55,0.93,0.44,0.52,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">experience. Soc Sci Med 59: 1529–1539.</text>
   <text y="353.071" x="315.099,318.586,322.073,323.8155,328.818,333.101,335.639,339.266,341.588,343.6093,346.109,348.578,350.3205,352.742,356.954,360.148,363.412,365.155,368.133,371.62,373.9201,376.381,382.846,384.5885,387.038,392.046,395.749,399.012,400.756,403.95,407.214,410.191,413.894,417.158,419.188,420.9305,423.432,428.878,430.6205,433.069,436.842,439.819,443.306,445.336,447.3573,449.792,456.257,457.9995,460.449,463.643,466.907,470.6011,473.034,476.661,479.708,482.21720000000005,484.713,491.178,494.226,496.764,501.485,504.5518,506.992,511.853,516.065,517.8075,520.257,523.305,525.3263,527.74,531.004,532.671,534.4135,536.868,538.534,542.021,545.508,548.995,552.482" svgx:width="0.5,0.5,0.25,0.55,0.61,0.36,0.52,0.33,0.29,0.55,0.35,0.25,0.55,0.6,0.46,0.47,0.25,0.43,0.5,0.33,0.55,0.93,0.25,0.55,0.72,0.53,0.47,0.25,0.46,0.47,0.43,0.53,0.47,0.29,0.25,0.55,0.78,0.25,0.55,0.54,0.43,0.5,0.29,0.29,0.55,0.93,0.25,0.55,0.46,0.47,0.53,0.55,0.52,0.44,0.36,0.55,0.93,0.44,0.36,0.68,0.44,0.55,0.7,0.6,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">35. Brust J, Lygizos M, Chaiyachati K, Scott M, van der Merwe TL, et al. (2010)</text>
   <text y="361.235" x="328.819,333.826,337.453,339.119,341.149,344.775,347.313,350.3798,352.741,357.748,361.235,364.938,368.132,371.18,373.718,376.041,377.784,381.271,384.9651,387.321,390.585,396.177,399.664,403.367,406.6429,408.976,414.57,417.038,422.1261,424.396,429.404,432.89,435.066,436.81,440.513,442.48,445.528,448.505,450.535,453.582,457.2064,459.487,465.952,469.578,471.245,473.274,475.018,478.644,481.183,484.809,488.171,490.347,495.431,498.478,500.801,502.544,504.866,506.896,510.159,513.862,515.8833,518.273,523.133,526.76,530.386,533.434,535.972,538.95,542.576,544.243,547.73,550.052,551.888" svgx:width="0.72,0.52,0.24,0.29,0.52,0.36,0.44,0.55,0.72,0.5,0.53,0.46,0.44,0.36,0.33,0.25,0.5,0.53,0.55,0.47,0.8,0.5,0.53,0.47,0.55,0.8,0.35,0.73,0.55,0.72,0.5,0.31,0.25,0.53,0.27,0.44,0.43,0.29,0.44,0.52,0.55,0.93,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31,0.73,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Culture Conversion among HIV Co-infected Multidrug-Resistant Tuberculosis</text>
   <text y="369.398" x="328.819,332.738,336.002,338.031,339.775,342.822,346.525,348.555,350.8551,353.252,354.995,358.6891,361.018,365.879,369.579,372.842,375.89,377.557,380.8329,383.127,386.977,390.025,392.563,395.101,398.376,400.1185,402.402,406.175,409.662,413.288,415.318,419.0121,421.393,426.115,427.998,430.536,432.279,435.257,438.521,440.2635,442.652,446.571,450.783,454.27,458.0338,460.395,466.128,471.358,475.7491,478.082,481.569,483.236,486.723,488.389,490.1315,492.481,495.968,497.711,500.759,504.246,507.733,511.219,514.706,518.193" svgx:width="0.56,0.47,0.29,0.25,0.44,0.53,0.29,0.33,0.55,0.25,0.53,0.55,0.7,0.52,0.47,0.44,0.24,0.47,0.55,0.55,0.44,0.36,0.36,0.46,0.25,0.55,0.54,0.5,0.52,0.29,0.53,0.55,0.68,0.27,0.36,0.25,0.43,0.47,0.25,0.55,0.56,0.6,0.5,0.54,0.55,0.82,0.75,0.63,0.55,0.5,0.24,0.5,0.24,0.25,0.55,0.5,0.25,0.44,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Patients in Tugela Ferry, South Africa. PLoS ONE 6(1): 6:e15841.</text>
   <text y="377.789" x="315.099,318.586,322.073,323.8155,328.818,334.412,337.46,339.126,340.793,343.841,346.35020000000003,349.284,354.144,355.8865,358.694,362.906,365.954,368.276,370.598,373.716,375.383,377.05,379.3501,382.22,387.304,389.0465,391.914,398.519,401.782,403.449,405.116,407.654,410.918,414.544,417.522,421.2161,424.113,429.12,430.8625,433.75,438.032,438.236,440.5361,441.298,443.836,447.54,449.283,452.547,456.25,459.514,463.14,465.462,468.51,472.2041,475.141,480.002,481.7445,484.608,489.615,493.102,496.589,499.783,502.8498,505.696,511.066,514.839,516.5815,519.415,522.463,524.4843,527.352,530.616,532.282,534.0245,536.876,538.543,542.03,545.517,549.064,552.551" svgx:width="0.5,0.5,0.25,0.55,0.8,0.44,0.24,0.24,0.44,0.36,0.55,0.7,0.25,0.55,0.6,0.44,0.33,0.33,0.44,0.24,0.24,0.33,0.55,0.73,0.25,0.55,0.95,0.47,0.24,0.24,0.36,0.47,0.52,0.43,0.53,0.55,0.72,0.25,0.55,0.61,0.47,0.33,0.55,0.36,0.53,0.25,0.47,0.53,0.47,0.52,0.33,0.44,0.53,0.55,0.7,0.25,0.55,0.72,0.5,0.5,0.46,0.44,0.55,0.77,0.54,0.25,0.55,0.44,0.29,0.55,0.47,0.24,0.25,0.55,0.24,0.5,0.5,0.5,0.5,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">36. Heller T, Lessells R, Wallrauch C, Ba¨ rnighausen T, Cooke GS, et al. (2010)</text>
   <text y="385.953" x="328.819,333.904,337.469,343.14,348.811,352.438,356.295,358.109,360.216,363.41,365.715,369.342,372.745,375.184,378.309,381.9334,386.7,388.808,391.472,394.598,397.94,400.047,405.718,408.844,412.625,414.6463,419.428,421.311,424.927,427.43620000000004,432.297,437.968,441.595,443.411,445.509,447.33,450.957,453.623,457.365,460.707,462.883,465.499,468.625,471.063,472.877,475.199,477.355,480.697,484.478,486.4993,491.281,493.379,497.12,500.748,503.924,506.532,509.588,513.215,515.031,518.603,520.926,522.798,525.0981,529.941,531.755,535.4491,540.202,542.867,546.494,549.16,552.502" svgx:width="0.72,0.5,0.8,0.8,0.52,0.53,0.25,0.29,0.46,0.31,0.52,0.47,0.33,0.44,0.52,0.55,0.29,0.36,0.44,0.47,0.29,0.8,0.44,0.53,0.29,0.55,0.27,0.5,0.36,0.55,0.8,0.52,0.24,0.29,0.25,0.52,0.36,0.52,0.47,0.31,0.36,0.44,0.33,0.25,0.33,0.29,0.47,0.53,0.29,0.55,0.29,0.52,0.52,0.44,0.36,0.43,0.52,0.24,0.5,0.33,0.25,0.33,0.55,0.25,0.53,0.55,0.36,0.52,0.36,0.47,0.24" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">Community-based treatment for multidrug-resistant tuberculosis in rural</text>
   <text y="394.116" x="328.819,334.265,338.987,342.25,346.679,350.305,351.972,355.689,357.865,363.095,366.359,368.388,371.652,373.319,375.0615,377.401,381.173,384.66,388.287,390.316,394.01009999999997,396.392,401.113,402.996,405.534,407.278,410.255,413.519,415.2615,417.65,420.119,423.822,425.8433,428.194,430.6335,432.957,437.817,441.517,445.143,448.191,450.729,453.7261,456.029,460.242,463.868,467.571,470.8469,473.206,478.506,480.249,482.5491,484.884,488.372,491.859,493.6015,495.939,499.426,502.913,506.4,509.887,513.374" svgx:width="0.78,0.68,0.47,0.63,0.52,0.24,0.52,0.31,0.75,0.47,0.29,0.47,0.24,0.25,0.55,0.54,0.5,0.52,0.29,0.53,0.55,0.68,0.27,0.36,0.25,0.43,0.47,0.25,0.55,0.35,0.53,0.29,0.55,0.35,0.55,0.7,0.52,0.52,0.44,0.36,0.43,0.55,0.6,0.52,0.53,0.47,0.55,0.76,0.25,0.33,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:AdvP49811;font-size:6.97px;stroke:none;">KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis 14: 420–6.</text>
   <text y="35.887" x="373.209,379.602,384.91,389.222,391.629,395.614,399.9178,402.518,406.503,409.07,413.055,416.873,419.527,426.166,430.151,434.551,437.1811,439.764,445.239,449.639,452.293,455.856,460.255,466.894,470.88,474.068,476.612,478.438,482.8215,485.456,487.361,491.761,496.24,498.065,501.883,506.2665,508.926,514.154,516.059" svgx:width="0.8,0.67,0.54,0.3,0.5,0.54,0.55,0.5,0.32,0.5,0.48,0.33,0.83,0.5,0.55,0.33,0.55,0.69,0.55,0.33,0.45,0.55,0.83,0.5,0.4,0.55,0.23,0.55,0.55,0.24,0.55,0.56,0.23,0.48,0.55,0.55,0.66,0.24,0.56" style="fill:rgb(0,0,0);font-family:AdvP403A40;font-size:7.97px;stroke:none;">MDR-TB Treatment Outcomes in Indian HIV</text>
   <text y="35.887" x="520.498" svgx:width="0.55" style="fill:rgb(0,0,0);font-family:AdvP697C;font-size:7.97px;stroke:none;">+</text>
   <text y="35.887" x="527.528,531.76,535.578,538.232,540.057,544.042,548.441,551.096" svgx:width="0.53,0.48,0.33,0.23,0.5,0.55,0.33,0.4" style="fill:rgb(0,0,0);font-family:AdvP403A40;font-size:7.97px;stroke:none;">Patients</text>
  </g>
  <rect style="stroke:blue;stroke-width:0.3;" x="58.054" y="758.784" height="16.951" width="18.005" title="9"/>
  <text y="758.784" class="image" id="image.9.1" width="18" height="16" x="58.054">image.9.1.58_76.759_776</text>
  <g begin="text">
   <text y="760.138" x="82.035,86.267,89.997,94.396,98.3013,100.913,106.388,111.617,115.5223,119.451,121.3638,125.347,131.237,137.127,143.017,144.675,149.234,151.059,155.459,158.511,162.911,167.31,171.295,172.953,177.353,179.919,184.3822,304.098,308.16270000000003,384.659,389.967,393.952,397.515,401.5,408.139,412.698,416.684,419.23440000000005,421.848,425.913,429.978,434.043,438.1077,442.03,443.9428,447.927,452.406,456.805,458.631,463.03,469.669,473.654,477.576,481.64070000000004,485.57,487.4828,491.466,493.371,496.519,499.668,504.067,508.052,511.989,516.054,520.1187,524.064,525.9767999999999,529.961,533.946,538.011,542.076,546.14,550.205" svgx:width="0.53,0.47,0.55,0.49,0.55,0.69,0.66,0.49,0.55,0.24,0.55,0.74,0.74,0.74,0.21,0.57,0.23,0.55,0.4,0.55,0.55,0.5,0.21,0.55,0.32,0.56,0.55,0.51,0.55,0.67,0.5,0.45,0.5,0.83,0.57,0.5,0.32,0.55,0.51,0.51,0.51,0.51,0.55,0.24,0.55,0.56,0.55,0.23,0.55,0.83,0.5,0.55,0.51,0.55,0.24,0.55,0.24,0.4,0.4,0.55,0.5,0.55,0.51,0.51,0.55,0.24,0.55,0.5,0.51,0.51,0.51,0.51,0.51" style="fill:rgb(0,0,0);font-family:AdvP403A40;font-size:7.97px;stroke:none;">PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28066</text>
  </g>
 </g>
</svg>
